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Abstract 
Enzymes are the bimolecular “workhorses” of the cell due to their range of 
functions and their requirement for cellular success. The atomistic details of how they 
function can provide key insights into the fundamentals of catalysis and in turn, provide a 
blueprint for biotechnological advances. A wide range of contemporary computational 
techniques has been applied with the aim to characterize recently discovered 
intermediates or to provide insights into enzymatic mechanisms and inhibition. More 
specifically, an assessment of methods was conducted to evaluate the presence of the 
growing number 3– and 4–coordinated sulfur intermediates in proteins/enzymes. 
Furthermore, two mechanisms have been investigated, the µ-OH mechanism of the 
hydrolysis of dimethylphosphate in Glycerophosphodiesterase (GpdQ) using five 
different homonuclear metal combinations Zn(II)/Zn(II), Co(II)/Co(II), Mn(II)/Mn(II), 
Cd(II)/Cd(II) and Ca(II)/Ca(II) as well as a preliminary study into the effectivness of 
boron as an inhibitor in the serine protease reaction of class A TEM-1 β-lactamases.  
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1.1 Enzymes 
The importance of enzymes to life cannot be understated because they are able to 
facilitate chemical reactions at life sustainable rates.1 They are by definition biocatalysts 
therefore they perform their function without being consumed in the reaction.1 What 
makes enzymes remarkable is that they are able to significantly enhance catalysis often at 
physiological conditions.2 A well-illustrated example of this is in the decarboxylation 
reaction of orotidine 5-phosphate. In absence of the enzyme, the decarboxylation process 
has half life of 78 million years, however, when orotidine 5-phosphate decarboxylase 
(ODCase) is present there is a 1017-fold rate enhancement that decreases the half-life to 
18 milliseconds.3 A second advantage of enzymes over traditional catalysts is its high 
selectivity. This may be best demonstrated in the family of aminoacyl-tRNA synthetases 
that can discriminate between serine and cysteine (differing by only a single atom) by a 
factor of 108.4-5 It is clear that enzymes have inherent properties that are important to 
deeply understand. 
1.2 Enzymatic Protection 
Enzymes have long list of functions,6 however protecting the cell from cellular stress 
can connect the work performed herein. There are three permutations of how an enzyme 
can alter a toxin to a less toxic forms: (1) they can catabolically break down the 
pathogen,7 (2) anabolically build a larger molecule,8-9 or (3) isomerize.10 Three topics 
where the enzyme’s role can be attributed to the breakdown down harmful toxins are 
described in the following sections. 
1.2.1 Protection from Oxidative Stress Using Sulfur 
Possibly the most unavoidable stressor that occurs in our cells is oxidative stress.11 
This is partly due to the necessity of oxygen to produce energy.12 In addition, intrinsic 
oxidative stress can be produced by enzymes themselves such as in the peroxisomes, 
during phagocytosis or as byproducts of standard P450 reactions.13-14 Oxidative stress can 
Chapter 1: Introduction 
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also be caused from extrinsic factors such as from UV radiation, exercise or toxins from 
air pollution or smoking.14 Consequently, the cellular defense mechanism is to produce 
antioxidants to remove them. Glutathione (GSH), lipoic acid, and coenzyme Q are small 
molecules natural antioxidants.15 However, several enzymes have evolved that can 
efficiently remove ROS as seen in catalase (CAT), glutathione peroxidases (GPx), 
thioredoxins (Trx), peroxiredoxins (Prx) and methionine (MSR) where more than 108 
ROS can be removed per second.13,16 
	  
Figure 1.1. Pictorial illustration of the sulfur intermediates that have been discovered or 
proposed to occur in various enzymes. Atom colours: yellow=S, orange=P, blue=N, red = 
O, grey=C and white=H. 
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Understandably, the source of enzyme’s catalytic power is important to study due to 
its efficiency and perhaps more importantly, the variability of the mechanism of action. 
For instance, CAT reduces ROS with an iron-heme group, Gpx uses selenium redox 
center, and the remaining enzymes: Trx, Prx, Srx and Msr utilize sulfur to rid of ROS. 
Due to the variability of the possible redox states for sulfur, nature utilized several unique 
3– and 4–coordinated sulfur intermediates to perform this function (Figure 1.1). These 
include: sulfuranes in archaeal thioredoxin peroxidase (ApTPx)17 and methionine 
sulfoxide reductase (Msr).18-19 In addition, sulfoxides,18,20 sulfonic acid,21 
sulfinamides,22-23 sulfenic acid phosphoryl esters,20 and sulfilimines24 have been found. 
These intermediates were assessed in Chapter 3 to set a foundation for future studies. 
1.2.2 Bioremediation Using GpdQ 
Organophosphates (OPs) are commonly used as insecticides to minimize crop 
damage.25-26 Unfortunately after a heavy rainfall, the OPs are washed away into the 
waterways where they can cause severe ailments in humans.27-28 It is estimated that 3 
million humans are affected from OP poisoning annually, therefore innovative solutions 
are required.29 One possibility is to use enzymes as a form of bioremediation because it is 
well known that certain enzymes have the inherent ability to break down phosphates.30-31 
The most ideal candidate would then have two properties: high catalytic rate and 
promiscuity.32 The latter is a necessary because OPs come in all different shapes and 
sizes Figure 1.2. A class of enzymes that fit this description is binuclear hydrolases. 
These include: OPH from Pseudomonas diminuta (PTE),33-34 purple acid phosphates 
(PAP),35-36 OpdA from Agrobacterium radiobacter, and glycerophosphosdiesterase from 
Enterbacter aerogene (GpdQ).37-38 GdpQ in particular, has the ability to decompose 
mono, di and triphosphoesters.39 However, the atomistic mechanistic details are not well 
defined. In Chapter 4, a possible catalytic mechanism for GdpQ was explored to gain a 
better understanding of how it performs its function. 
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Figure 1.2. Select organophosphates that can be cleaved using bioremediation. Atom 
colours: pink=P, yellow=S, blue=N, red=O, grey=C and white=H. 
1.2.3 Inhibition of a Bacterial Resistance Mechanism  
In some cases, enzymatic protection mechanisms work against us. This is true in case 
of bacterial resistance. Bacteria have evolved to protect themselves from potent external 
toxins, i.e. antibiotics.40 Some antibiotics function by blocking bacterial transpeptidases 
activity in penicillin-binding proteins (PBPs) that are responsible for building their cell 
walls.41 This has been an extremely successful target for inhibition due to the lack of cell 
walls in mammals. However, enzymes known as β-lactamases have developed over their 
evolution that are able to hydrolyze these antibiotic before they can inhibit the PBPs.42-43 
Today there have been about 1300 distinct subclasses have been identified and various 
approaches for inhibiting these enzymes are required.43-44 One approach is to use boron as 
a Lewis acid because β-lactamases are often serine proteases that initiate through a 
nucleophilic attack.45 Boron’s empty p-orbital would, in theory, be a great electrophile to 
increase reactivity.46-47 This feature would commence a unique reversible mechanism that 
has not been energetically characterized. Chapter 5 studied this possibility. 
1.3 Computational Enzymology 
Computation is a cost efficient strategy to understand properties of enzymes. Perhaps 
one of the strongest advantages of this field is its ability to characterize short-lived 
OP Nerve agent VX Bis(p&nitrophenyl)phosphate1 p&nitrophenyl1phosphate1
Dimethyl phosphate Ethyl Methylphosphate 
!!
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intermediates and transition states that would be extremely difficult or impossible to do 
experimentally.48-49 Such atomistic details can provide an unprecedented foundation for 
rational design of biomimics or therapeutics. A multi-scale computational enzymology 
approach is used in this thesis.49 This includes the combination of small models, quantum 
mechanical clusters, quantum mechanics/molecular mechanics, molecular dynamics as 
well as docking to investigate enzymes in the various systems that have been discussed. 
1.4 References 
1. Voet, D.; Voet, J. G.; Pratt, C. W., Brisbane: John Willey and Sons 1999. 
2. Wolfenden, R.; Snider, M. J., Acc. Chem. Res. 2001, 34 (12), 938-945. 
3. Miller, B. G.; Wolfenden, R., Annu. Rev. Biochem. 2002, 71 (1), 847-885. 
4. Zhang, C.-M.; Christian, T.; Newberry, K. J.; Perona, J. J.; Hou, Y.-M., J. Mol. 
Biol. 2003, 327 (5), 911-917. 
5. Fersht, A. R.; Dingwall, C., Biochemistry 1979, 18 (7), 1245-1249. 
6. Cooper, G. M.,"The Central Role of Enzymes as Biological Catalysts". The Cell: 
A Molecular Approach. 2nd Edition. 2000. 
7. Zanger, U. M.; Schwab, M., Pharmacol. & Therapeut. 2013, 138 (1), 103-141. 
8. Ketterer, B.; Coles, B.; Meyer, D. J., Environ. Health Perspect. 1983, 49, 59. 
9. Lushchak, V. I., J. Amino Acids 2012, 2012. 
10. Cummins, I.; Dixon, D. P.; Freitag-Pohl, S.; Skipsey, M.; Edwards, R., Drug 
Metab. Rev. 2011, 43 (2), 266-280. 
11. Finkel, T.; Holbrook, N. J., Nature. 2000, 408 (6809), 239-247. 
12. Federico, A.; Cardaioli, E.; Da Pozzo, P.; Formichi, P.; Gallus, G. N.; Radi, E., J.  
Neurol. Sci. 2012, 322 (1), 254-262. 
13. Pham-Huy, L. A.; He, H.; Pham-Huy, C., Int. J. Biomed. Sci.: IJBS 2008, 4 (2), 
89. 
Chapter 1: Introduction 
7	  
	  
14. Sosa, V.; Moliné, T.; Somoza, R.; Paciucci, R.; Kondoh, H.; LLeonart, M. E., 
Ageing Res. Rev. 2013, 12 (1), 376-390. 
15. Johansen, J. S.; Harris, A. K.; Rychly, D. J.; Ergul, A., Cardiovas. Diabetol. 2005, 
4 (1), 5. 
16. Nordberg, J.; Arner, E. S., Free Radic. Biol. Med. 2001, 31 (11), 1287-1312. 
17. Nakamura, T.; Yamamoto, T.; Abe, M.; Matsumura, H.; Hagihara, Y.; Goto, T.; 
Yamaguchi, T.; Inoue, T., P. Natl. Acad. Sci. 2008, 105 (17), 6238-6242. 
18. Robinet, J. J.; Dokainish, H. M.; Paterson, D. J.; Gauld, J. W., J. Phys. Chem. B 
2011, 115 (29), 9202-9212. 
19. Dokainish, H. M.; Gauld, J. W., Biochemistry 2013. 
20. Rhee, S.; Jeong, W.; Chang, T.; Woo, H., Kidney Int. 2007, 72, S3-S8. 
21. Tasaki, T.; Sriram, S. M.; Park, K. S.; Kwon, Y. T., Annu. Rev. Biochem. 2012, 
81, 261. 
22. Fu, X.; Kassim, S. Y.; Parks, W. C.; Heinecke, J. W., J. Biol. Chem. 2001, 276 
(44), 41279-41287. 
23. Fu, X.; Mueller, D. M.; Heinecke, J. W., Biochemistry 2002, 41 (4), 1293-1301. 
24. Vanacore, R.; Ham, A.-J. L.; Voehler, M.; Sanders, C. R.; Conrads, T. P.; 
Veenstra, T. D.; Sharpless, K. B.; Dawson, P. E.; Hudson, B. G., Science. 2009, 325 
(5945), 1230-1234. 
25. Pope, C. N., J. Toxicol. Environ. Heal. B. 1999, 2 (2), 161-181. 
26. Fenske, R. A.; Lu, C.; Simcox, N. J.; Loewenherz, C.; Touchstone, J.; Moate, T. 
F.; Allen, E. H.; Kissel, J. C., J. Expo. Sci. Environ. Epidemiol. 2000, 10, 662-671. 
27. Grandjean, P.; Landrigan, P. J., The Lancet Neurology 2014, 13 (3), 330-338. 
28. Eddleston, M.; Street, J. M.; Self, I.; Thompson, A.; King, T.; Williams, N.; 
Naredo, G.; Dissanayake, K.; Yu, L.-M.; Worek, F., Toxicology 2012, 294 (2), 94-103. 
29. Bird, S. B.; Sutherland, T. D.; Gresham, C.; Oakeshott, J.; Scott, C.; Eddleston, 
M., Toxicology 2008, 247 (2), 88-92. 
Chapter 1: Introduction 
8	  
	  
30. Mitic, N.; Smith, S. J.; Neves, A.; Guddat, L. W.; Gahan, L. R.; Schenk, G., 
Chem. Rev. 2006, 106 (8), 3338-3363. 
31. Wille, T.; Scott, C.; Thiermann, H.; Worek, F., Biocat. Biotransfor. 2012, 30 (2), 
203-208. 
32. Sutherland, T.; Horne, I.; Weir, K.; Coppin, C.; Williams, M.; Selleck, M.; 
Russell, R.; Oakeshott, J., Clin. Exp. Pharmacol. Physiol. 2004, 31 (11), 817-821. 
33. Horne, I.; Sutherland, T. D.; Harcourt, R. L.; Russell, R. J.; Oakeshott, J. G., Appl.  
Environ. Microbiol. 2002, 68 (7), 3371-3376. 
34. Benning, M. M.; Shim, H.; Raushel, F. M.; Holden, H. M., Biochemistry 2001, 40 
(9), 2712-2722. 
35. Schenk, G.; Guddat, L.; Ge, Y.; Carrington, L.; Hume, D.; Hamilton, S.; De 
Jersey, J., Gene 2000, 250 (1), 117-125. 
36. Gahan, L. R.; Smith, S. J.; Neves, A.; Schenk, G., Eur. J. Inorg. Chem. 2009, 
2009 (19), 2745-2758. 
37. Scott, C.; Pandey, G.; Hartley, C. J.; Jackson, C. J.; Cheesman, M. J.; Taylor, M. 
C.; Pandey, R.; Khurana, J. L.; Teese, M.; Coppin, C. W., Indian J. Microbiol. 2008, 48 
(1), 65-79. 
38. Schenk, G.; Mitić, N. a.; Gahan, L. R.; Ollis, D. L.; McGeary, R. P.; Guddat, L. 
W., Acc. Chem. Res. 2012, 45 (9), 1593-1603. 
39. McLoughlin, S. Y.; Jackson, C.; Liu, J.-W.; Ollis, D. L., Appl. Environ. 
Microbiol. 2004, 70 (1), 404-412. 
40. Stewart, P. S.; Costerton, J. W., The lancet 2001, 358 (9276), 135-138. 
41. Walsh, C., Nature 2000, 406 (6797), 775-781. 
42. Bush, K.; Jacoby, G. A.; Medeiros, A. A., Antimicrol Agents Chemother. 1995, 39 
(6), 1211. 
43. Bush, K., Ann. N. Y. Acad. Sci. 2013, 1277 (1), 84-90. 
Chapter 1: Introduction 
9	  
	  
44. Jacoby, G.; Bush, K., Lahey Clinic,[cited May 14, 2014] Available from: 
http://www. lahey. org/Studies 2012. 
45. Crompton, I.; Cuthbert, B.; Lowe, G.; Waley, S., Biochem. J. 1988, 251, 453-459. 
46. Drawz, S. M.; Babic, M.; Bethel, C. R.; Taracila, M.; Distler, A. M.; Ori, C.; 
Caselli, E.; Prati, F.; Bonomo, R. A., Biochemistry 2009, 49 (2), 329-340. 
47. Tan, Q.; Ogawa, A. M.; Painter, R. E.; Park, Y.-W.; Young, K.; DiNinno, F. P., 
Bioorg. & Med. Chem. Letters. 2010, 20 (8), 2622-2624. 
48. Walpole, J.; Papin, J. A.; Peirce, S. M., Annu. Rev. Biomed. Eng. 2013, 15, 137. 
49. Gherib, R.; Dokainish, H. M.; Gauld, J. W., Int. J Mol. Sci. 2013, 15 (1), 401-422. 
	  
	  
	  
 
Chapter 2 Theoretical 
Methods 
	  
MOLECULAR)DOCKING) MOLECULAR)DYNAMICS)
QM/MM)QM)CLUSTER)
Chapter 2: Theoretical Methods  
11	  
	  
2.1 Introduction  
Computational chemistry can be defined as a toolbox of computer-facilitated-
techniques with the purpose to understand numerous chemical phenomena.1 These 
include but are not exclusive to: molecular geometries, energetics, reactivity, IR, UV, 
NMR and EPR.1 One particular field in computation chemistry that has gained recent 
global recognition is multi-scale modeling of complex systems.2 Contributions to its 
development awarded Karplus, Levitt and Warshel the Nobel Prize in chemistry in 
2013.2-3 In this thesis, contemporary multi-scale modeling techniques were used to study 
biological enzymes and the underlying concepts for these methods. Specifically, 
molecular and quantum mechanics are described in this chapter. 
2.2 Computational Chemistry in Biological Systems 
The focus of this work is computational investigations into biological systems, i.e. 
understanding the atomistic details that occurs within living organisms. Biological 
systems contain numerous macromolecules such as lipids, nucleic acids, carbohydrates 
and proteins that can sometimes be very difficult to study experimentally.4 For example, 
it can be difficult to determine a catalytic mechanism of a protein (enzyme) or to monitor 
the dynamics of a lipid membrane without the aid of calculation due to their size and the 
time scale of which they occur.5-6 Computational chemistry has the ability to provide 
insight into these features; however, there are still numerous challenges that must be 
addressed. A marriage of accuracy and efficiency must be sought after to provide 
meaningful results in a timely matter. For example, it is now possible to accurately 
calculate properties dipeptides using high-order correlated wave function based methods 
to excruciating accuracy.7 However, an enzyme can be 1000+ fold larger and it is just not 
feasible to take on that approach. In addition to size, biological processes occur over a 
large time scale, ranging from femtoseconds to seconds, Figure 2.1.6,8-10 Strategic 
approaches must be used to overcome such chemical diversity to pull out useful valuable 
information. One approach, for example, is to use molecular dynamics simulations that 
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use simpler mathematical formulae such as classical mechanics to evaluate how protein 
motion over longer periods of time. Moreover, more complex quantum mechanical 
methods can look at only the specific atoms involved in catalysis that occurs over 
picoseconds.11 Combining two or more methods to attempt to fully describe these 
systems are commonly referred to as multi-scale enzymology.12-13 
 
Figure 2.1. A pictorial illustration of a wide range of timescales that is relevant to 
studying biological systems.10 
	  
PART 1 
2.3 Molecular Mechanics 
Molecular mechanics (MM) is the simplest method to describe how a molecular 
system behaves. An analogy that is often used to describe MM is that it is a “ball & 
spring” approach.14 Atoms are treated as spherical point charges that are connected 
through a potential “spring”.14 Consequently, this method cannot model a chemical 
reaction because the behavior of individual electrons are not properly described.14-15 
However, this method does have great application because several chemical processes do 
not require bond orders to change in order to characterize a system. Examples include: 
energy minimizations, protein folding over time or quantifying binding interactions.16 
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The driving force of molecular mechanics can be summed into three terms; atomic 
position    𝑟 ,  force 𝐹 𝑟  and potential energy 𝑈(𝑟) . The relationship between these 
variables is shown in Equation 2.1. 
 
𝐹 𝑟 = −   𝜕𝑈(𝑟)𝜕𝑟  
 
(2.1) 
 
In a typical molecular mechanics calculation, the initial atomic coordinates (𝑟) are 
required. When studying proteins, the source of these coordinates is often X-ray 
crystallographic or NMR derived data that can be found in the protein data bank (PDB). 
Next, an approximation of the potential energy 𝑈(𝑟) is calculated. This is possible by 
using an empirical function known as a force field (FF), Equation 2.2. The FF can be 
thought of mathematical equivalent of “a bridge” between atomic position and how they 
influence one another. Unfortunately, a universal formula does not exist therefore, the 
one selected for calculation is chosen based on the system that for which it was built. 
CHARMM,17-18 AMBER19-20 and MMFF9421 are good FFs to use when studying 
proteins. All these force field have the general equation, Equation 2.2: 
 𝑈!"!#$=  𝑈!"#$ + 𝑈!"!"# +   𝑈!"!!"#$% + 𝑈!"# + 𝑈!"#$"%& (2.2) 
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Figure 2.2. A ball and stick representation of the general terms that are considered in 
molecular mechanics. 
Each potential (U) term in Equation 2.2 houses a different internal equation. The first 
three terms are intramolecular parameters.   𝑈!"#$  is the potential energy stored in 
covalent bonds. 𝑈!"#$%  represents three-center bond angle. 𝑈!"!!"#$%  represents the 
torsion (dihedral) angle that describes relationship between two atoms that are three 
covalent bonds apart where the central bond is free to rotate. The final two terms in 
Equation 2.2 are intermolecular interactions. 𝑈!"# represents the van der Waal’s forces 
and  𝑈!"#$"%& represents the electrostatic interactions. The solution of 𝑈!"!#$ will give a 
potential energy that is representative of the starting atomic coordinates. Finally, since the 
potential and coordinates are now known, the force applied on each atom can be 
determined as per Equation 2.1. From this point, Newton’s second law can relate position 
(r) to time (t) to create a trajectory for the atoms. This is the foundation of molecular 
dynamics.  
2.3.1 Molecular Dynamics  
Molecular dynamics (MD) contains the mathematical equations to predict how 
molecules in a system move over a period of time. Alder and Wainwright were the 
founders of modern day MD.22-23 However, the first molecular dynamic simulation 
performed on biological relevant molecules occurred in 1977 when Nobel Prize laureate 
Karplus and coworkers studied bovine pancreatic trypsin inhibitors (BTPI, 910 atoms).24 
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This simulation was performed over 9.2 ps.24-25 Today, a 103-fold to 106-fold increase 
(nanoseconds to microseconds) can be performed in a simulation.  
A general scheme to a MD simulation is outlined below: 26 
1. Assign initial position to atoms r (t = 0). This usually comes from 
crystallographic data.  
2. Prepare and parameterize the system. Crystallographic data does not include 
the position of hydrogen atoms and the structure is generally strained in 
ordered to produce the crystal. Therefore the valence is satisfied by the 
addition of the appropriate number of hydrogen atoms, re-solvated, and 
energy minimized using molecular mechanics.  
3. Choose an appropriate ∆t and total time-scale. Generally speaking, for 
enzymatic systems, ∆t is between 1-2 fs and total time is between 1 - 1000 ns. 
The total will vary based on what is being calculated. The reason for a 
seemingly small ∆t is that the error is proportional to ∆t2 thus cannot be too 
large or the calculation becomes unreliable. 
4. Calculate the potential energy function. Using an empirical force field and 
convert this energy into a force function, Equation 2.1. 
5. Move the atoms. Determine new atomic positions using Newtonian 
equations, Equations 2.3 and 2.4.  
 
 
 𝐹 𝑟 =   𝑚  𝑎(𝑟) (2.3) 
 
 
 𝑟   𝑡 + ∆𝑡 = 𝑟   𝑡 + 𝑣 𝑡 ∆𝑡 + 12𝑎∆𝑡! (2.4) 
 
where 𝑡 =    ∆𝑡 
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6. Repeat. Recalculate potential as in step 4 continue until total time-scale is 
met. 
 
There are different algorithms that exist for MD simulations that all use, in some form, 
this general outline. In this thesis, the Nanoscale Molecular Dynamics (NAMD) program 
is used to perform the simulations.27 NAMD is tailored to study large bimolecular 
systems such as proteins, as well as lipid membranes.27  Another benefit is that it has 
efficiently integrated the Newtonian equations while adequately controlling the 
temperature and pressure of the system. This is a necessity for accuracy in physiological 
conditions.27-28 It is accepted that NAMD is well-suited for running such simulations.28 
2.3.2 Molecular Docking 
A second common application of MM in studying biological systems is molecular 
docking. This allows one to explore several conformations of a ligand in a receptor-
binding site. The purpose of docking is often to find and rank the optimal binding 
geometries and associated energies with the use of a scoring function.29 As a 
computational chemist, there are several efficient docking programs that exist such as 
DOCK,30 AutoDock,31 FlexX,32 GOLD,33 and GLIDE.34 Docking has gathered great 
interest for both experimentalist and computational chemist alike. This is illustrated by 
the massive increase in publications that contain a docking protocol, Figure 2.3. For 
instance, since the turn of the century, there have been over 35000 publications that 
include molecular docking. 
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Figure 2.3. The total number of publications that involve a molecular docking study as a 
stand-alone or a complement to experimental work. Data collected from Web of Science 
using the criteria Topic = molecular docking. 
	  
There are three structural components to consider in a docking simulation:35 
1. Receptor  
2. Pocket  
3. Ligand 
In the case of proteins, the receptor is the entire protein. The pocket is the specific 
region that the ligand directly interacts with. This can be a pre-defined pocket or the 
entire surface of the protein if it is not known. Finally, the ligand is the molecule whose 
binding is of interest. In general, there are five steps that occur during a docking 
procedure that have been used herein that are outlined below 4.35-37 
1. Conformational analysis is to explore different intramolecular conformations 
that are favourable in energy. This will scan favourable torsion angles and will 
not alter the bond lengths or the 3-center bond angles (this may be altered in the 
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refinement stage). There may be tens of thousands different possibilities found 
and any duplicates and ones that have steric clash are deleted.  
2. The placement stage involves putting the resulting conformers into a 
predefined receptor pocket in several orientations that fit. Here, hundreds of 
structures are generated.  
3. The first scoring step: is then used to rank all the determined structures. There 
are several different types of scoring functions that exist.36 The one that is used 
in this thesis is the London dG scoring function35 (Equation. 2.5). 
 ∆𝐺 = 𝑐 + 𝐸!"#$ + 𝑐!"𝑓!"!!!"#$% + 𝑐!𝑓!!!!"# + ∆𝐷!!"#$%  !  (2.5) 
 
where c is the average gain or loss of entropy from rotation and translation. This 
allows the calculation to be ∆𝐺 instead of just the potential enthalpy ∆𝐻. 𝐸!"#$ is 
the flexibility of the ligand. 𝑐!" is the energy of an ideal hydrogen bond whereas 𝑓!" calculates the imperfections that will deviate it from the ideal (coefficient 
would be between 0 and 1). 𝑐!𝑓!!!!"#  deals with metals and ∆𝐷!   measures 
the desolvation of an atom.  
4. Refinement: Once all the poses are scored, the user defines the number of poses 
that are allowed to enter the second stage of docking. The pocket up to this point 
is strictly rigid and has not adjusted to this ligand. The refinement uses a MM 
force field minimization of the protein receptor side chains to help relax the side 
chains to fit that pose.  
5.  The second rescoring will then calculate the energy of binding again and rank 
the new list after minimization giving an output of the top pose.  
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All the aforementioned methods use classical mechanics as the foundation of their 
calculations. When the chemistry of bond formation and breaking is important to the 
chemical system, a more sophisticated theory is required. This is known as quantum 
mechanics. 
 
PART 2 
2.4 Quantum Mechanics  
A brief introduction into the foundational equations of quantum mechanics is 
discussed. To start, the most famous equation that is associated with the words “quantum 
mechanics” is no doubt the Schrödinger equation (Equation 2.6).  
 𝐻𝜓 = 𝐸𝜓 (2.6) 
 
where 𝐻 is the Hamiltonian operator, 𝜓 is the wave equation and E is the energy 
eigenfunction. The wave equation, which cannot be experimentally measured, is 
postulated to contain all possible information regarding the chemical system.38 Thus, a 
Hamiltonian operator can act on the wave equation to extract specific energies about that 
system. The total molecular Hamiltonian operator is: 
 
𝐻!"! = − 12 ∇!!!!!! − 12 1𝑀!!!!! ∇!! − 𝑧!𝑟!"!!!!!!!! + 𝑧!𝑧!𝑟!"!!!!!!!! + 1𝑟!"!!!!!!!!  (2.7) 
 
where i and j represent different electrons and A and B represent different nuclei. The 
first two terms are kinetic terms of the electrons and nuclei respectively. The next three 
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terms are the potential energy terms for electron-nuclear, nuclear-nuclear and electron-
electron interactions respectively. Unfortunately, the total molecular Hamiltonian is too 
difficult to solve exactly therefore approximations are introduced.38 The first of which is 
the Born-Oppenheimer (BO) approximation. Since a nucleus is about 103 fold more 
massive than an electron, the kinetic energy is negligible for the nuclei with respect to the 
electrons. This can set the nuclear kinetic energy to 0. In addition, the nuclear-nuclear 
repulsion potential and can be approximated to a constant. After these two 
simplifications, the resultant is the electronic Hamiltonian, Equation 2.8. 
 
𝐻!"!# = − 12 ∇!!!!!! −    𝑧!𝑟!"!!!!!!!! + 1𝑟!"!!!!!!!!  (2.8) 
 
This the starting point to solve for the energy of a system. The only term that is not 
straightforward to solve is the final election-electron repulsion term in a many electron 
system. An accepted way to treat this is to assume that the each electron moves 
independently. This gives rise to a series of one-electron spin orbitals, Hartree-product, 
that are much easier to treat mathematically.38-39 There are several different ways to 
further describe the electrons in a QM calculation that varies based on the approximations 
used. Nevertheless, at the foundation is the Hartree-Fock method that treats the electrons 
as an average “smeared” electrostatic potential.38 As one can imagine, averaging 
electrons over space can lead to large errors because in a real system the motion of each 
individual electron influences each other.  
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2.4.1 Higher Order Correlation Methods 
The difference in energy between the HF electron averaging, 𝐸!" ,  and the real system, 𝐸!"#$% is known as electron correlation 𝐸!"##, Equation 2.9. Higher order correlation 
methods have been developed to minimize the discrepancy between these two terms.40-41 
	  
𝐸!"#$% =   𝐸!" +   𝐸!"## (2.9) 
 
There are two high order correlation methods, out of many, that are used in thesis, 
quadratic configuration interaction of singles and doubles (QCISD) and Möller Plesset 
perturbation doubles (MP2).38, 40-41 In the former, new determinates are added to the HF 
wavefunction as a means to promote electrons to virtual orbitals. If all the possible 
excitations are included this would be called full-CI and the exact energy of the system 
would be known.42 As described by the name, QCISD allows for only single and double 
excitations.  
In the latter case, MP2 uses perturbations to treat the electron correlation. They are 
often referred to as MPn methods where n is the order.38 Furthermore, the order 
represents the number of terms in the Taylor Series that are calculated. The pitfall for 
solving both of these post Hartree-Fock methods is that they are very costly in terms of 
the time it takes to achieve this accuracy. For example, QCISD scales N6 and MP2 ~ N5, 
where N is size of the system.40 Therefore, higher order correlation methods are often 
restricted to studying small systems. 
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2.4.2 Density Functional Theory 
Fortunately, there exists an alternate theory that can synergize efficiency with 
accuracy known as density functional theory (DFT). DFT is different from wavefunction-
based methods because is uses an electron probability density function, an observable 
property. Its aim is to calculate all physical ground state chemical properties from only 
the electron density.38 The electron probability density function is the chance of finding 
electron in a predefined space, Equation 2.10.43  
 
 
This equation comes with benefits compared to conventional wavefunction methods. 
The function is dependent on a total of three spatial components, x, y and z regardless of 
the size of the molecule. In contrast, wavefunction methods are dependent on three 
spatial and one spin component. This reduces the complexity of the equations used and in 
result speeds up calculations considerably.  
The pitfall for DFT is the relationship between the electron density and the energy of 
the system is not known. However, it was eventually shown that the exact energy can be 
divided into five terms Equation 2.11:44 
 
 
Where 𝐸! is the kinetic energy of non interacting electrons, 𝐸!is the total nuclear 
potential that includes nuclear-electron attraction and nuclear-nuclear repulsion, 𝐸! is the 
electron potential that includes the electron-electron repulsion and 𝐸!"is the exchange 
𝜌   𝑥,𝑦, 𝑧 𝑑  𝑥  𝑑𝑦  𝑑𝑧 (2.10) 
𝐸!"#$% 𝑝 = 𝐸! 𝑝 + 𝐸! 𝑝 + 𝐸! 𝑝 + 𝐸!" 𝑝  (2.11) 
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correlation. Unfortunately, there is no known solution for the 𝐸!"  term therefore it is 
approximated.44 This is why there are several functionals that exist that are trained 
against certain types of systems. It is important to know the limitation of each functional 
used to gauge the accuracy of the results produced.  
2.5 Quantum Mechanics/Molecular Mechanics 
Finally, the pioneer work combining quantum mechanics and molecular mechanics 
(QM/MM) was done by the Nobel laureates Warshel and Levitt in 1976.45 To illustrate 
the growth of the QM/MM method, there have been over 100 unique studies on different 
enzymes every year since 2007.46 The aim of quantum mechanics/molecular mechanics is 
to combine two theories to use large models with high accuracy without substantially 
increasing the amount of time it takes to run a calculation. This method brings in the best 
of both methods. 
 To briefly describe the QM/MM model, the inner subsection is treated with quantum 
mechanical methods that adequately describe how the electrons behave, commonly 
representing the active site of enzymes. Molecular mechanics is used as a cheap method 
to incorporate steric effects of thousands of atoms that surround the active site in the 
outer subsection. By using this method, proteins that are thousands of atoms in size can 
now be submitted to calculation.  
2.6 Technical Aspects and Units  
All calculations in this thesis were performed with the Gaussian 09 suites of 
programs,47 NAMD27 or within the Molecular Operating Environment (MOE) software.35 
The relative energies are reported as kilojoules per moles (kJ mol-1). The conversation 
factor from hartree (h) is  
1 h = 2625.5 kJ mol-1 
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3.1 Introduction 
The sulfur atom that is found in two of the amino acids, cysteine and methionine, 
predominately exists in a mono-coordinated (anionic cysteine) or di-coordinated (neutral 
cysteine, methionine or in disulfide bridges) state. However, a modest number of 
naturally occurring 3– and 4–coordinated sulfur intermediates have been revealed 
experimentally by spectroscopy or theoretically using computational methods.1-6 These 
include unique 4-coordinate organosulfuranes found in archaeal thioredoxin peroxidase 
(ApTPx)1 and methionine sulfoxide reductase (Msr).2 In addition, various 3-coordinate 
sulfur centers have been also observed, including sulfoxides (RS(O)R`),2,7 sulfonic acid 
(RSO3H) in ubiquitin-dependent proteasomes,5 sulfinamides (RS(O)NR`) in 
myeloperoxidase,6,8 sulfenic acid phosphoryl ester in sulfiredoxins (Srx),7 and 
sulfilimines (RS=NR`) collagen IV,9 see Figure 3.1. Several studies have examined these 
structures experimentally to an extent and some insights have been determined towards 
their characterization.1,5-7,9 Nevertheless, out of the aforementioned list of enzymes, only 
two have been examined computationally: ApTPx1 and Msr.2,10 
In ApTPx, a novel sulfurane was crystalized for the first time at a resolution of 1.77 Å 
and an electron density suggested a covalent bond between γ-SCys50 and histidine (His), 
δ1-NHis42.1 The distance between the two central atoms was found to be 2.21 Å. The 
authors performed quantum mechanical (QM) calculations to characterize the nature of 
this bond. Using small models at the B3LYP/6-31G* level of theory, they concluded the 
formation of a sulfurane with two possible protonation states for His42 (see Figure 3.1).1  
 
Chapter 3: Assessment of 3– and 4–coordinated Sulfur Species in Biological Systems 
 
30	  
	  
	  
Figure 3.1. Illustrations of several 3– and 4–coordinated sulfur intermediates found in 
various proteins that were investigated in this study. 
The second sulfurane intermediate found in Msr was characterized exclusively by 
computation.2 This intermediate was first shown in the subclass MsrB using a QM cluster 
approach. Various models with small to modest basis sets, 3-21G* and 6-31G(d) for the 
large and smaller model respectively, were employed using the B3LYP functional.2 They 
showed that the sulfurane was composed of a methionine group bound to a cysteinyl S– 
and a hydroxyl group (see Figure 3.1). Similar results were obtained for the sister 
enzyme MsrA where a more extensive ONIOM (QM/MM) approach at the 
ONIOM(B3LYP/6-311+G(2df,p):AMBER96)//ONIOM(B3LYP/6-31G(d):AMBER96) 
level of theory.10 
It is important to note all previous computational studies on these species have chosen 
the B3LYP functional at a modest basis set for their investigation.1-2,10 Although this 
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functional is extensively used and is generally reliable for a wide range of systems, to our 
knowledge, its behavior when studying these sulfur intermediates has never been 
explicitly assessed. Previously, Pearson et al. assessed a series of organoselenium, 
selenoxides and some divalent sulfur compounds using various density functional theory 
(DFT) methods.11-12 They showed that B3PW91 at 6-311(2df,p) was the best level of 
theory to use and smaller basis sets such as 6-31G(d,p) predicted geometries in almost 
equal accuracy as larger basis sets.11-12 Herein we used various common DFT functionals 
including the newer hybrid meta–GGA functionals with respect to 3– and 4–coordinated 
sulfur species found in biological systems. This will provide a reliable level of theory 
that can be used as a reference for any further computational studies to describe the 
diversity in sulfur chemical bonding. 
 
3.2 Computational Methods 
All calculations were performed with the Gaussian 09 suite of programs.13 A series of 
commonly used DFT functionals in studying enzymatic catalysis were considered. 
Specifically, the hybrid Becke’s three-parameter hybrid exchange functional14-15 with 
either the Lee–Yang-Parr16 (B3LYP) or the Perdew–Wang–199117-18 (B3PW91) 
correlation functional were tested. In addition, the M06 suite of functionals meta-GGA 
M06L19 and the meta-hybrid-GGA functionals MO620-21, MO62X20 and MO6HF20 were 
also considered. These functionals were evaluated systematically using a wide range of 
Pople basis sets: 6-31G(d), 6-31G(d,p), 6-311G(d,p), 6-311+G(d,p), 6-311G(2d,p), 
6-311G(df,p), 6-311+G(2df,p), 6-311G(d,p) to 6-311+G(3df,3pd). The employed basis 
sets represent a single change from a previous one, for instance, the addition of a 
d-function or an f-function to heavy atoms or diffuse functions. The exceptions are 
6-311+G(2df,p) and 6-311+G(3df,3pd), which represents the cumulative expansion of all 
previously listed. All benchmark calculations were performed using high level ab initio 
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methods, quadratic configuration interaction with singles and doubles excitations 
(QCISD) and the second–order Møller–Plesset perturbation (MP2) at the 6-311+G(2df,p) 
or 6-311++G(3df,3pd) level of theory as indicated. All calculations were performed in 
gas phase with a dielectric of 1 with the exception of the ethyl sulfinic phosphoryl ester 
found in Srx. In this case, the calculations were performed using a dielectric of 4 
(IEFPCM) to increase the stability of the existing two negative charges in the absence of 
any stabilizing group. All bond lengths and obtained energetics are reported in Å and kJ 
mol-1, respectively.  
Prior to exploring the previous discussed 3– and 4–coordinated sulfur species, we 
constructed two series of small molecules starting from sulfenic acid and sulfoxide 
tautomeric structures (Figure 3.2) to elucidate the effect of chosen level of theory with 
respect to geometries and energetics. In the former series, sulfenic acid derivatives were 
increased in size and conjugation, Figure 3.2a. The latter series was mainly used to allow 
us to assess the effect of changing the level of theory on relative energies as well as 
introducing 3–coordinated sulfur species, Figure 3.2b. 
Based on the results of the two aforementioned series, eleven 3– and 4–coordinated 
sulfur based intermediates were modeled from their native structures in proteins 
including truncated models of the involved amino acids, Figure 3.3. For example, an 
imidazole ring was used represent the histidyl residues in ApTPx. Additionally, cysteine 
and methionine were truncated to include only ethylthiol and ethylmethylsulfide moiety, 
respectively. Finally, in collagen IV, lysine was represented by a methylamine moiety. 
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Figure 3.2. Schematic illustrations of the compounds used in the systematic study of a) 
sulfenic acid derivatives and b) sulfoxides derivatives. 
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Figure 3.3 Schematic illustrations of the eleven modeled 3– and 4–coordinated sulfur 
compounds found in 6a,b) ApTPx, 7a–c) Srx, 8) Ubiquitin–dependent proteasomes, 9a–
b) Msr 10) Collagen IV and 11) Myeloperoxidase.  
 
3.3 Results and Discussion 
One of the main challenges in any computational study is to know the limitations of 
the employed methods. The use of small models helps to overcome this obstacle by 
allowing for highly accurate computational methods to be used as a reference to assess 
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different DFT functionals. These are commonly applied to model large biological 
systems with lower computational costs. Therefore, the correlation methods, QCISD and 
MP2 calculations at 6-311+G(2df,p) or higher (as indicated) were used to reference 
energetics and geometric parameters. 
In general, from all structures considered, the main differences in geometries were 
found to occur in bonds that have atoms that have equal or greater electronegativity than 
sulfur. Interestingly, the bond lengths in some of these cases deviated from the 
benchmark calculations up to and occasionally exceeding 0.1 Å. In contrast, sulfur–
carbon and sulfur–hydrogen bonds deviated from the benchmark calculations minimally, 
rarely exceeding 0.01 Å. For this reason, only the former bond types will be discussed in 
the following sections.  
3.3.1 Geometrical Assessment of Sulfenic Acid and Sulfoxide Derivatives   
3.3.1.1 Series 1: Sulfenic Acid Derivatives  
Sulfenic acid has been shown to be a common starting point for cysteine derived 3– 
and 4–coordinated structures found in biological systems.1, 22 In this series, five different 
derivatives of sulfenic acid were assessed (Figure 3.2a). Notably, irrespective of the 
structure used, we noticed a specific ordering of the employed functionals with respect to 
the S–O distance. This order did not change upon the increase of the basis set. Therefore 
in the following section we discuss the ethyl sulfenic acid as it is represents the entire 
series well and is most similar to cysteine sulfenic acid (Figure 3.4). 
In general, the S–OH bond is described well independently of the choice of the 
functionals considered. Indeed, the maximum difference in S–OH distance between these 
functions is less than 0.04 Å, Figure 3.4. Although this may apply to small models, in 
proteins this may not the case and the differences are expected to be larger due to the 
surrounding interactions. Comparing our two–benchmark methodologies, QCISD and 
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MP2 at the 6-311++G(3df,3pd), the difference between them is minimal at 0.005 Å. With 
respect to the benchmark, our calculations show that in general, B3LYP always 
overestimates the S–OH bond distance. Unlike B3LYP, other functionals were found to 
approach the benchmark as we increase the basis set. In particular, B3PW91 and M06L 
were found to overestimate the distance at smaller basis set, however at 6-311+G(2df,p) 
and 6-311++G(3df,3pd) give a similar results to the benchmark. Interestingly, M06, 
M062X and M06HF approach the benchmark at a moderate basis set, 6-311G(2d,p) and 
6-311G(df,p), At smaller and larger basis sets, they were found to overestimates or 
underestimate the bond distance respectively. It is important to mention that in small 
models the application of a high basis set is feasible whereas in larger models the 
computational cost limits the size of the employed basis set to a moderate size such as: 6-
31G(d) or 6-31G(d,p). Therefore, the application of DFT in computational enzymology 
depends on finding a exchange correlation functional that behaves close to the 
benchmark at moderate basis set.  
These results highlight the applicability of these DFT functionals in small as well as 
larger protein models. For instance the B3PW91 and M06L are best in comparison to the 
benchmark at a high basis set. However, the results show that the hybrid meta-GGA 
Minnesota functionals: M06, M062X, M06HF would be better suited for modeling at a 
smaller basis set, one that is appropriate for studying protein system. Specifically, the 
difference from 6-31G(d,p) and the benchmark to these functionals is minimal. 
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Figure 3.4. Plot of the optimized r(S–OH) bond distances in Å for ethyl sulfenic acid 
(EtSOH) Figure 3.2, 3a. Color-coding Blue: B3LYP, Dark Red: B3PW91, Purple: 
M06HF, Green: M06, Orange: M062X and Teal: M06L. QCISD/6311++G(3df.3pd) and 
MP2/6-311++G(3df,3pd) in black and red respectively. 
	  
3.3.1.2 Series 2: Sulfoxide Derivatives 
In general, methionine sulfoxide commonly produced in proteins as a result of 
methionine’s reaction with reactive oxygen species and is involved in protein 
regulation.23 Here, as indicated in the methodology, for general assessment, a second 
series of a simple sulfoxide (ethyl sulfoxide) derivative was investigated. As seen in 
Figure 3.5, unlike sulfenic acid, there are no distinct groupings of functionals, GGA, 
meta-GGA and hybrid meta-GGA, with respect to their performance. Similar to sulfenic 
acid, the S=O difference was used as the main criteria to assess the functionals 
geometrical parameters. The maximum difference in distance from the benchmark is 
0.033 Å. As in previous the case, both QCISD and MP2 benchmark calculations are very 
similar, 0.003 Å. Interestingly, B3LYP and M06HF are now almost identical, 
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overestimating the S=O length to the greatest extent. The M06 suite of functionals M06, 
M062X and M06L, performed best at moderate basis sets. By increasing the size of the 
basis set, more fluctuation occurs during the systematic improvement of the optimized 
geometries. For instance, adding an extra d-functions from 6-311G(d,p) to 6-311G(2d,p) 
showed larger relative improvements for all functionals than adding a diffuse or 
f-functions. This improvement has been suggested before because adding d-functions 
allows for a better description of the interaction between the S=O bond.24 
	  
Figure 3.5. Plot of the optimized r(S–OH) bond distances in Å for ethyl sulfoxide (EtSO) 
Figure 3.2, 3b. Benchmark:  Color-coding- Blue: B3LYP, Dark Red: B3PW91, Purple: 
M06HF, Green: M06, Orange: M062X and Teal: M06L. QCISD/6311++G(3df.3pd) and 
MP2/6-311++G(3df,3pd) in black and red respectively. 
Collectively, B3PW91, B3LYP and M06HF all behave well with respect to modeling 
small molecules at a very high basis set. However, at a smaller basis set, 6-311G(2d.p), 
M06L, M062X and B3PW91 would be suitable for small model. At a moderate basis set, 
6-31G(d,p) and 6-311G(d,p), M06L, M06 and M062X are best feasible choice for 
modeling enzymes.	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In summary considering functional behaviors in both the sulfenic acid and sulfoxide 
series, modeling enzymatic catalysis of sulfur containing species would be best 
performed with meta-hybrid-GGA M06 and M062X at a moderate basis set of 
6-31G(d,p) for geometrical optimization. 
	  
3.3.1.3 Determination of Relative Energy Trends Between Sulfur Tautomers 
Since the previous section provided a reference for calculating geometries in sulfur 
containing species, our second goal is to determine how the relative energy would change 
with respect to the level of theory used. This carried out by calculating the differences in 
energies between the sulfenic acid derivatives and their corresponding sulfoxides. For the 
two previous discussed derivatives, ethyl sulfenic acid and ethyl sulfoxide (Figure 3.6,a), 
the benchmark results showed a relative energy difference of 32.9 and 41.7 kJ mol-1 for 
MP2 and QCISD, respectively. Unlike the geometrical parameters, the choice of DFT 
functionals and basis sets has considerable implications on energetics, as shown in Figure 
3.6b.  
Using a small basis set, except M06L, can lead to large over approximations in the 
obtained relative energies. Even the best performing functional, B3PW91, deviates from 
the QCISD benchmark by at least 42.4% (17.7 kJ mol-1) and the worst, M06HF, differs 
by 175.1% (73.0 kJ mol-1). Although M06L differs by from the QCISD benchmark by 
only 0.7% (0.3 kJ mol-1), there is a general decline in accuracy upon increasing the size 
of basis set. This is contrasted by the remaining functionals that improve considerably 
upon increasing basis sets. Specifically, adding extra d-functions (2d) provides the 
greatest improvements and any basis set that does not include at least extra d-functions 
would not be recommended. 
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Notably, the percentage of Hartree-Fock (HF) appears to systematically affect the 
functional's performance. As in M06HF which contains 100% HF, energy values have 
the largest deviations whereas M06L with zero HF is the closest to the benchmark at 
moderate basis sets. In addition, B3LYP, B3PW91 and M06, all have between 20-27% 
HF, performs similarly and very well at a high basis set, 6-311+G(2df,p) with respect to 
the benchmark. Therefore, they are better suited for energies in enzymatic catalysis. 
	  
Figure 3.6. a) Schematic showing an example of the difference between one of the five 
tautomers used to compare relative energies. b) Plot of the relative energy values after 
optimization for the tautomers of ethyl sulfenic acid and ethyl sulfoxide. Color-coding- 
Blue: B3LYP, Dark Red: B3PW91, Purple: M06HF, Green: M06, Orange: M062X and 
Teal: M06L. QCISD/6311++G(3df.3pd) and MP2/6-311++G(3df,3pd) in black and red 
respectively. 
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3.3.2 Applications Into Biologically Relevant Intermediates 
It must be noted the results of the simple di and tri–coordinated sulfur are proposed 
precursors but may not translate to the larger and more complex systems situated in 
proteins where the bond types may vary greatly. Therefore, herein, all suggested sulfur 
species have been examined, highlighting the new types of bonds when appropriate. 
3.3.2.1 Archaeal Thioredoxin Peroxidase (ApTPx) 
The first biological system subject to analysis is from archaeal thioredoxin peroxidase 
(ApTPx). This enzyme is mainly responsible for reducing oxidative stress via the 
reduction of hydrogen peroxide molecules.1 Here, a unique covalent bond between the 
γSCys50 and the neighboring histidine (His), δ1–NHis42 was proposed by Nakamura et al.1 
according to the obtained electron density from the crystal structure. Based on 
B3LYP/6-31G*, the authors suggested two possible “hypervalent” sulfuranes to be a part 
of the enzyme's mechanism (Figure 3.3, 6 a,b). The sulfur has a hydrogen atom bound to 
its center and they differ only upon the protonation state of His42.  
3.3.2.1.1 The Sulfurane with a Neutral Histidine 
Both QCISD and MP2 calculations gave similar results with respect to the distance 
between S–OH and S–N. In addition, the performances of variant DFT functionals are in 
agreement with the benchmarks. More specifically, for the S–OH bond, the order of the 
functionals is consistent with the S–OH in series 1 (Figure 3.4 and 3.7a); B3LYP, 
B3PW91 and M06L resulted in longer distances with respect to the hybrid meta-GGA 
M06 functionals. However in this case, increasing the size of the basis set does not 
systemically improve the obtained distances. Notably, smaller basis set performs at the 
same accuracy as the largest basis sets. Increasing the valence description, using triple ζ, 
and adding diffuse functions had the largest negative effect on the bond description by 
about 0.02 Å each. A better performance could be achieved by adding more polarized 
functions to the heavy atoms.  
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For the S–N interaction, similar to the S–OH bond, the variations were minute with 
respect to the employed functionals (Figure 3.7b). In general, with the exception of 
M06HF, there is a positive correlation between size of basis sets and overall 
performance. B3LYP and M06L predict the longest distance. M06 and M062X are the 
closest to the benchmark. M06HF performs well at small basis set however at higher 
basis sets it grossly underestimates the bond distance and would not be recommended. 
3.3.2.1.2 The Sulfurane with a Protonated Histidine  
Here, the MP2 calculations do not match the QCISD benchmark (Figure 3.7 c,d). 
Specifically, they deviate by 1.4% (0.023) and 6.4% (0.143 Å) with S–OH and S–N 
bonds, respectively. Thus, a third ab initio method CCSD/6-311G(d,p) was tested as a 
reference, showing an agreement with QCISD results. Therefore, in the following 
discussion we used the results of QCISD as the reference. In contrast to the neutral 
sulfurane, the overall increase of the basis set improved the S–OH bond length by about 
0.025 Å in total towards the QCISD benchmark (Figure 3.7b). The ordering of the 
functionals for S–OH is similar to the previous case. Again, the best performing 
functionals are the hybrid meta-GGA M06 functionals. For S–N interaction, significant 
differences were found to occur with respect to the employed functionals. However, the 
M06 functional was found to be agreement with the QCISD benchmark. The B3LYP and 
M06L slightly overestimate the bond distance and in contrast, the M062X and B3PW91 
slightly underestimate the bond distance. Notably, increasing the size of the used basis 
set has a minimal effect on the obtained results. In M06HF, the bond is grossly 
underestimated and closely resembles the MP2 results.  
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Figure 3.7. Plots for optimized bond lengths of a) S–OH, b) S–N of un-protonated for 
hydroxy-imidazolyl-λ4-sulfanylmethane and c) S–OH and d) S–N of protonated for 
hydroxy-imidazolyl-λ4-sulfanylmethane from Figure 3.3, 6a and b. Color-coding- Blue: 
B3LYP, Dark Red: B3PW91, Purple: M06HF, Green: M06, Orange: M062X and Teal: 
M06L. QCISD/6-311+G(2df,p) and MP2/6-311+G(2df,p) in black and red respectively. 
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Overall, with the two different bond types considered the best preforming functional is 
either M06 or M062X, as it consistently lies relatively close or closest to the benchmark 
calculations. In this case when the imidazole is protonated the functionals shows more 
discrepancy when describing the structure, particularly in the S–N interaction. Small 
basis sets such as 6-31G(d) and 6-31G(d,p) perform nearly as well as the extremely large, 
6-311++G(3df.3pd). This is a desirable feature when using large models. Unfortunately, 
these results cannot be directly compared to the crystal structure S–N bond length of 2.21 
+/- 0.13 Å due to the fact that the distances would likely differ based on the surrounding 
environment.   
	  
3.3.2.2 Sulfiredoxins (Srx) 
This enzyme is of particular significance because the substrate and two of its 
intermediates are all 3–coordinated. Srx catalyzes the reduction of cysteine sulfinic acid 
(CysSO2H) to sulfenic acid.7 The two proposed intermediates along the reaction 
coordinate are sulfinic phosphoryl ester and thiosulfinate (Figure 3.1). Both of these 
incorporate new bond types not explored thus far, these include: S–OPO3-2, SO–PO3-2 
and S–S(O). 
3.3.2.2.1 Sulfinic acid  
This molecule is generally formed as a result of the over-oxidation of the cysteinyl 
residue(s) in proteins. This molecule contains two bond types that have already been 
evaluated in the general assessment, S=O and S–OH. The only difference was that the 
sulfur oxidation state changed from 0 in sulfenic acid to +2 in sulfinic acid. The 
behaviors of these bond types are virtually identical to the trends outlined in the general 
assessment (refer back to Figure 3.4 and 3.5). This indicates that different sulfur redox 
states are described consistently between functionals for these small molecules.  
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3.3.2.2.2 Sulfinic Phosphoryl Ester 
For this intermediate, the S–OPO3-2 bond and the SO–PO3-2 bond are of interest 
(Figure 3.3, 7b). Unlike previous gas phase calculations, the sulfinic phosphoryl ester 
was optimized in a dielectric of 4 due to the presence of two negative charges. A 
dielectric of 4 was used because it represents a reasonable polarity of an active site 
environment.25 
First, the S–OPO3-2 bond was found to be described in a similar way to the sulfoxides 
of the S=O bond with respect to functional behavior as we increase the basis set (Figure 
8a). The inclusion of more d-functions (2d) and removing the diffuse functions improves 
the bond description by 0.015 Å. Contrariwise, the oxygen/phosphate, SO–PO3-2 bond 
has a mirrored relationship of the sulfur/oxygen, S–OPO3-2, bond (Figure 3.8b) and 
notably, the inclusion of (2d) now worsen the results for the SO–PO3-2. Aside from that, 
increasing the size of the basis was found to overall improve the obtained geometries. As 
previous, the M06, M062X and M06HF performed best to the benchmark.  
3.3.2.2.3 Thiosulfinate  
This is similar to a disulfide bond with the difference of one the sulfurs is oxidized to 
a sulfoxide. (Figure 3.3, 7c). One sulfur has a +1 oxidation state next to a sulfur with a -1 
oxidation state, the R–S(O)–SR’ functional group. Since S=O behaves similarly with all 
prior S=O examples, only the S–S bond will be discussed herein. 
A larger variation was found to occur to with respect to the S–S bond, Figure 3.8c. 
The maximum deviation from the benchmark is found using B3LYP at all basis sets. The 
best performing functional at smaller basis sets are M062X. 
Overall to generalize the choice of functional to use with the these types of 
intermediates in enzymes, it is found that the M062X functional consistently falls closest 
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or among the closest at a level of theory that is appropriate for studying proteins, 
6-31G(d,p). 
 
Figure 3.8. Plot of the optimized for a) the SO–PO-2 bond and b) S–OPO-2 bond 
distances in Å for ethyl sulfinic phosphoryl ester representing the first intermediate in 
Srx from Figure 3.3, 7b and c) the S–S bond distances of thiosulfinate representing the 
second intermediate in Srx Figure 3.3, 7c. Color-coding- Blue: B3LYP, Dark Red: 
B3PW91, Purple: M06HF, Green: M06, Orange: M062X and Teal: M06L. 
QCISD/6-311+G(2df,p) and MP2/6-311+G(2df,p) in black and red respectively. 
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3.3.2.3 Ubiquitin-dependent Proteasomes 
Ubiquitin-dependent proteasomes are responsible for the degradation of proteins in 
the cell by recognizing the irreversible over oxidation of cysteinyl residue(s) into sulfonic 
acid.26-27 In sulfonic acid, the sulfur center has an oxidation state of +4 and found to 
behave similarly to its precursor sulfinic acid intermediate. The S–OH bond displayed a 
similar trends with respective to increasing basis set as the S=O bond, in series 2 (Figure 
3.5). The basis set 6-311G(2d,p) performs best compared other than the two highest basis 
sets studied.  
3.3.2.4  Methionine Sulfoxide Reductase (Msr A & B) 
Msr is the first system under investigation whose precursor is methionine. Methionine 
in biological systems is readily oxidized to methionine sulfoxide and it is thought to be 
important in protein regulation as well as an oxidative defense method.2 The two 
enzymes MsrA and MsrB catalyze the reduction of S– and R–epimers of methionine 
sulfoxide respectively.2 For this enzyme, there are two molecules under investigation; a 
sulfurane and the other is a unique sulfonium cation intermediate that is formed along the 
proposed reaction pathway.2 Here, two bond types are of interest, first the S–S bond in 
both intermediates and second, the S–OH bond in the sulfurane. In general, the bond 
lengths in the sulfurane were found to be more dependent on the functional used than in 
the sulfonium cation and will be emphasized more extensively (Figure 3.9).  
For the sulfurane, for S–S bond B3LYP as seen before, predicts lengths furthest from 
the benchmark (Figure 3.9a). Furthermore, there was a general systematic increase with 
performance with respect to increasing the basis set. The M06 and M062X functional are 
the closest at smaller basis sets.  For the sulfonium cation, at a small basis set M062X, 
M06HF and M06L are very close to the QCISD benchmark (Figure 3.9b). Increasing the 
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valence description and adding diffuse functions without the incorporation of extra d or 
f-functions were found to worsen the results with respect to the smaller basis sets.  
	  
Figure 3.9. Plots of the optimized for S–S bond distances in Å for a) sulfurane, from 
Figure 3.3, 9b. b) sulfonium cation, from Figure 3.3, 9c from Msr A and B. c) S–OH 
bond distances in the sulfurane intermediate. Color-coding- Blue: B3LYP, Dark Red: 
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B3PW91, Purple: M06HF, Green: M06, Orange: M062X and Teal: M06L. QCISD/6-
311+G(2df,p) and MP2/6-311+G(2df,p) in black and red respectively. 
Unlike the sulfurane, M06 was not amongst the top the performing functionals. As 
with the sulfurane S–S bond, the basis set can have a considerable impact on the S–OH 
bond lengths (Figure 3.9c). As before, it was beneficial to add diffuse functions however 
in this case, their addition elongates the S–OH by near 0.085 Å, or 4.4%. Although the 
smaller basis set describes the S–OH bond accurately, it does poorly for the S–S bond. 
Moreover, modest size basis set, 6-311G(d,p) to 6-311+G(d,p) describes the S–S bond 
well, they do not perform well for the S–OH. Thus, a larger basis set is required when 
doing characterization of this intermediate, such as 6-311G(2d,p). Unfortunately, today 
this size of basis set is not yet feasible to study enzymatic systems. Overall, the M062X 
functional collectively performs best with the two bond types and would be appropriate 
for studying enzymatic systems 
 
3.3.2.5 Collagen IV 
Recently a new type of bond was found for protein crosslinking in collagen 
introducing the R2S=NR. Collagen is required for the integrity of tissues in a wide 
variety of organisms.9 This structure has a double bond between the sulfur in methionine 
with the nitrogen of a nearby lysine residue. Consequently, this preforms comparably to 
the S=O bond of the sulfoxides. Interestingly, in this case all functionals studied with the 
exception of B3LYP, behave virtually identically, Figure 3.10 Thus solely out of looking 
at the S=N bond, out of the functionals studied, the choice is not as significant for this 
system. It is interesting that the all the DFT functionals do not approach the QCISD 
benchmark at the highest level of theory as it often does in the previous cases. 
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Figure 3.10. Plot of the optimized for S=N bond distances in Å of the sulfimine protein 
cross linker found in collagen IV. Color-coding- Blue: B3LYP, Dark Red: B3PW91, 
Purple: M06HF, Green: M06, Orange: M062X and Teal: M06L. QCISD/6311+G(2df.p) 
and MP2/6-311++G(3df,3pd) in black and red respectively. 
	  
3.3.2.6. Myelpersoxidase  
Finally, when looking at myelpersoxides, there is a 3–coordinated sulfur with a S–N 
single bond, sulfinamide. Myelpersoxides are heme-enzymes that are released by 
pathogen combatting enzymes to form hypohalous acids (HOX, X is a halogen).8 The 
hypohalous acids can then produce sulfinamide or sulfonamide.  
In this structure, we are only considering the behavior of functionals with respect to 
the S–N as the S–O bond is quite similar to previous cases, Figure 3.11. Both B3LYP 
and M06L are similar and the furthest from the benchmark. M06HF again found to 
deviate from the benchmark as we increase the basis set. Furthermore, M062X was found 
to be the best with a systematic increase in the performance with respect to basis set. 
1.55	  
1.56	  
1.57	  
1.58	  
1.59	  
r(
S=
N
)	  
Basis	  Set	  
Chapter 3: Assessment of 3– and 4–coordinated Sulfur Species in Biological Systems 
 
51	  
	  
	  
Figure 3.11. Plot of the optimized for S–N bond distances in Å of the sulfinamide 
protein cross linker found in Myelpersoxidase. Benchmark QCISD 6-311++G(3df,3pd) 
from Figure 3.3, 11. Color-coding- Blue: B3LYP, Dark Red: B3PW91, Purple: M06HF, 
Green: M06, Orange: M062X and Teal: M06L. QCISD/6311++G(3df.3pd) and MP2/6-
311++G(3df,3pd) in black and red respectively. 
	  
3.4 Conclusions  
In this study the performance of several DFT functionals with different sized basis 
sets were assessed with respect to higher ab initio QCISD and MP2 benchmarks 
calculations dealing with several proposed 3– and 4–coordinated sulfur species in 
biochemistry. First, two series of molecules were evaluated including sulfenic 
acid/sulfoxide derivatives in which the geometric parameters and energetics were used as 
the criteria for the performance of the level of theory. Second, the previously purposed 
3– and 4–coordinated species in ApTPx, Srx, Ubiquitin-dependent proteasomes, MsrA 
and B, Collagen IV and Myeloperoxidase were evaluated and found in some cases to be 
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highly dependent on the level of theory used. General remarks upon the performance of 
each functional are summarized below. 
• B3LYP, in general was found to have the greatest overestimation 
of the investigated bond distances especially at small to moderate size basis 
sets in virtually all cases. In particular, very large basis sets are often required 
to approach to the benchmark calculations with respect to geometric 
parameters. However with respect to energetics, B3LYP performed on par 
with the other functionals. This highlights its limitation in describing 3– and 
4– coordinated sulfur species and thus would not be recommended for 
geometric optimizations.  
• B3PW91 was found to perform slightly better than B3LYP. 
Furthermore, with respect to relative energies, it performs almost identically 
to B3LYP.  
• M06HF performance varied depending on the system under study. 
For instance, in sulfenic acid it was found to the best functional to predict the 
S–OH bond at a small basis set. However, for the sulfoxide, it was found to be 
the worst functional to describe the S=O bond. In addition, the predicted 
relative energies were found to be the highest with a great deviation from the 
benchmark. Thus, although it behaves well with respective to certain species, 
it is often not recommend for studying these types of bonds.  
• M06L was one of the best performing functionals with respect 
with S=O bond. However, for S–OH and S–S the results are moderate and 
similar to B3PW91. With respect to energy evaluation, M06L predicted 
values close to the benchmark at a smaller basis set and deviated away from 
the benchmark as the level of theory increased. In general its performance is 
moderate to poor with respect to geometric optimization. 
Chapter 3: Assessment of 3– and 4–coordinated Sulfur Species in Biological Systems 
 
53	  
	  
• M06 and M062X, both functionals were always found to be the 
best in describing the investigated molecules. In particular at smaller basis 
sets, applicable for studying large systems, they were found to be the closest 
and reliable to the ab initio benchmark calculations. Similarly for energetics, 
they are among the best functionals to be used. Thus both functionals are 
recommended for studying 3– and 4–coordinated sulfur systems.  
• In general our results show the percentage of HF in each 
functional appears to be correlated to its performance; this is especially 
evident when looking at energetics with 100% or 0 HF. The largest deviations 
occur with M06L and M06HF. In addition, B3LYP, B3PW91 and M06, all 
have between 20-27% HF, performs similarly and very well at a high basis 
set, 6-311+G(2df,p) with respect to the benchmark. Therefore, they are more 
suited for energies in enzymatic catalysis.  
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4.1 Introduction 
Organophosphate (OP) poisoning is a global health concern that affects more than 
3-million people in the developing world due to its high neurotoxicity.1 Exposure leads to 
several ailments such as seizures, paralysis, and cardiac conduction disorders that can 
ultimately lead to death.1-3 To cease the use of OPs is not likely due to several industrial 
and military applications.4-6 For example, they are one of the most commonly used types 
of pesticides marketed worldwide; present in about one-third of all pesticides.4,6 
Unfortunately, OPs often unintentionally end up in water supplies and are difficult to 
remove.5 There are currently a few common treatment options to degrade phosphates into 
smaller and usually unharmful forms these include: chemical hydrolysis/oxidation by 
advanced oxidation processes (AOPs)7-8 or the use of UV radiation.9 However in large 
bodies of water, these methods can be expensive, non-specific and risk secondary 
contamination.10 An alternative strategy is bioremediation, which uses enzymes to 
breakdown these harmful agents. This method is thought to have large potential because 
the degradation process is catalytic and specific to OPs. Furthermore, they are considered 
“greener” because biocatalysts are readily biodegradable.11 
There have been several enzymes that have been proposed to be potential 
bioremediators for OPs and they belong to the family of binuclear metallohydrolases12-15 
These include: OP hydrolase from Agrobacterium radiobacter (OpdA)12 and from 
Pseudomonas diminuta (OPH/PTE),13 purple acid phosphatase (PAP)14-15 from mammals 
and plants, and Glycerophosphodiesterase (GdpQ) from Enterobacter aerogenes.13, 16 
Interestingly, despite having remarkably similar catalytic active sites, they have very 
different catalytic rates and degrees of promiscuity.17-20 OpdA/PTE are the most effective 
with a natural turnover number (kcat) close to 104 s-1 and an catalytic efficiency (kcat/Km) 
value of 108 M-1 s-1.17-18 PAP have a kcat of about 400 s-1 with a kcat/Km value of 103 M-1 
s-1,20 whereas GdpQ is the least efficient with both catalytic turnover and kcat/Km of about 
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1.19 In terms of promiscuity, however, GpdQ is the only one that is readily reactive 
against all three types of phosphoesters (mono, di and tri) whereas the others tend to have 
only monoesterase with slight diester activity (PAP) or triesterase activity (OpdA).20-21 
This feature has promoted GpdQ as a high potential candidate for bioremediation 
especially if the catalytic activity is enhanced. There has been an effort to achieve this; a 
500-fold increase in catalytic activity was achieved by altering only its oligiometric 
structure.22 
	  
Figure 4.1. Comparing the similar active site of three different classes. A) OdpA/PTE12-
13, b) PAP 14-15 and c) GpdQ13,16 with their presumed native metal composition 
GpdQ’s reactivity can also be enhanced by altering the metal combination present in 
the active site.19 It has been suggested that the native composition is heteronuclear and 
most likely contains Fe(II) in the α-site and the β-site is Zn(II).19, 23 A study performed by 
Daumann et al. investigated the effect of various metal combination on the catalytic rates 
using Bis(p-nitrophenyl) phosphate (bpNPP).19 They determined an empirical reactivity 
series of Zn(II) < Co(II) < Mn(II) < Cd(II).19 Furthermore, both kcat and kcat/kM are higher 
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when the metals in the active site are the same, M(II)/M(II), opposed to the Fe(II)/M(II) 
combinations.19  
A single mechanism is not likely due to GpdQ’s activity in a large pH range, 3.0–11.0; 
an optimum pH that varies from 5.0 to 9.0 depending on the substrate used.16,21-23-24	  
Experimental studies performed by Hadler et al. has proposed that there is terminal 
water/hydroxide located on the α-metal that acts as a nucleophile (Figure. 4.2).22 
However, it should be noted that the pKa of the terminal water was found to be between 9 
and 10.19 This mechanism is plausible at alkaline pHs but may not be the predominate 
route at a neutral or acidic pH. An alternative mechanism where the bridging µ–OH as 
the nucleophile has been proposed to occur in PAPs Figure 4.2 which has a similar active 
site composition.25 Therefore, it is possible that a single mechanism is not sufficient to 
explain the full range of activity associated with this enzyme. 
	  
Figure 4.2. The mechanism for the a) terminal hydroxide based hydrolysis of a general 
diphosphate by GpdQ21-22 vs. b) the bridging hydroxide mechanism proposed mechanism 
of PAP.25 
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Recently, Gherib et al. begun to provide insights into the terminal water vs. µ–OH 
nucleophile hypothesis of dimethylphosphate (DMP) via computation.26 Using quantum 
mechanical cluster calculation B3LYP/6-31G(d) level of theory, they showed a large gain 
in entropy drove DMP to bind bidentate displacing the terminal water.26 The change in 
Gibbs free energy of the bidentate ligation process was -33.2 kJ mol-1 more favourable 
than when the terminal water was present.26 In addition, they suggested the critical role of 
an acidic His81 in the second coordination sphere to facilitate catalysis. 
Herein we used a quantum mechanics/molecular mechanics (QM/MM) approach to 
continue the investigation the possibility of a µ–OH mechanism in GpdQ. Since the 
approximate homonuclear kcat are known for the phosphodiester bpNPP, an investigation 
its catalytic source was performed. In addition, a QM cluster approach investigated the 
roles of the residues in the α-site by in silico mutagenesis on most efficient metal 
combination Cd(II)/Cd(II). The aim was to quantify the changes in structural parameters 
and the activation barriers to provide useful information for the rationale design of 
biomimics.	  
4.2 Computational Methods 
4.2.1 Preparation of the QM/MM Model 
  The crystal structure PDB ID: 3D0327 was used as the starting point for the for the 
GdpQ model. This structure did not have a substrate bound in the active site therefore a 
molecular docking protocol was used within the molecular operating environment (MOE) 
software.28 The reason for choosing dimethylphosphate (DMP) as the substrate was three-
fold, (1) the experimental kcat is for a phosphodiester (2) its small size is more cost 
effective for the quantity of QM/MM calculation performed and (3) a study for Co(II)-
GpdQ have shown that rate limiting step for phosphodiester cleavage is dictated, at least 
partially, by cleavage.21  
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The specific docking protocol used the induced fit formalism, specifically with the 
London dG scoring function and AMBER12EHT force field for minimization.28 This 
generated the Michaelis complex for which the quantum mechanics/molecular 
mechanism (QM/MM) model was built. The quantum mechanical (QM) layer of the 
QM/MM model consisted of the full substrate, metals, the first coordination sphere and 
two residues from the second coordination sphere, a methionine and histidine for a total 
of 101 atoms Figure 4.3. The molecular mechanics layer contained 933 atoms that 
surrounded the QM layer. The α-carbons in the MM region were fixed outside the third 
coordination sphere to allow for sufficient flexibility in the active site and to keep the 
integrity of the overall enzyme structure. 
	  
Figure 4.3. The QM/MM model used in the study of GpdQ. The QM layer is shown in 
the foreground and the MM layer is faded in the background for clarity. Atom colours, 
Red=O, Blue=N, Orange=P, Dark Yellow=S, Grey=C, White=H, Pale Yellow=general 
metal. 
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4.2.2 QM/MM Calculations 
All calculations were performed using the Gaussian 09 suite of programs.29 The 
geometry calculations were completed using several different functionals that have been 
used to describe metals in enzymes. In particular the hybrid functionals B3LYP,30 
B3LYP*31 (15% Hartree-Fock contribution) were used, as well as the meta-GGA 
functional M06L,32 and hybrid meta-GGA functionals M0633 and MPWB1K.34 All 
optimizations used a 6-31G(d) basis set. Frequency calculations were performed on the 
reactant, transition state and product complexes to ensure that the reactants and products 
were at a minimum and that the transition state was at a maximum saddle point, 
(indicated by only positive and a single negative frequency value(s), respectively). The 
optimized structures were submitted to single points calculations using a much larger 6-
311G(2d,2p) basis set. For the Mn(II) and Co(II) metals that can occupy several spin 
states, previous preliminary work in our group has shown that the lowest energy 
electronic configuration is when both metals occupy the high spin state.26 Finally, natural 
bond order (NBO) analysis was performed at the same level of theory as the 
optimizations to get the partial charges of each atom after truncating the QM/MM model 
to remove the MM layer and replacing the boundary with hydrogen caps.  
4.2.3 Quantum Mechanical Cluster Calculation of Cd(II)/Cd(II) Complexes 
Based off of the results from the first part of the study, the hybrid meta-GGA M06 
functional for predicting activation barriers was used. The model was identical to the QM 
layer of the QM/MM model and the boundaries between the QM and MM were capped 
similarly to the NBO calculations. The α-carbons were then fixed to maintain the active 
site integrity. In the absence of a MM layer, single points used IEFPCM solvation method 
with a dielectric constant of 4.0 to simulate the presence of a protein environment. In 
general, the native α-site consists of Asp and His residues. A stepwise systematic change 
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of single, double and triple mutations from Asp to His and vice versa were performed to 
evaluate how each change can influence catalysis between each variant. 
4.3 Results and Discussion 
4.3.1 Reproducing the Catalytic Mechanism 
Previously, our group has investigated the catalytic mechanism of the heteronuclear 
combinations of Fe(II)/M(II)-GpdQ, where M(II) can be Zn(II), Co(II), Mn(II) or Cd(II), 
using a quantum mechanical cluster approach.26 It was suggested that the mechanism was 
energetically favoured to undergo the µ–OH nucleophilic mechanism with the 
requirement that His81 acts as a catalytic acid.26 Herein, we continued to explore this 
mechanism with homonuclear M(II)/M(II) combinations. It has been experimentally 
shown that the homonuclear derivatives have much higher catalytic turnover rates than 
the Fe(II)/M(II) counterpart and the reason behind its rate should be explored.19 Several 
DFT methods were used in an effort to remove any systematic anomalies that could arise 
from a single method interpretation. This approach was similar to what was done in the 
study of PAP25 and OpdA.35 Furthermore, this study used a quantum 
mechanical/molecular mechanics model. This may enhance the study because it has been 
shown that the third coordination sphere is important structural integrity of the enzyme 
and hydrogen-bonding networks may facilitate catalysis.19, 27 
There are three possibilities for the cleavage of DMP using the µ–OH nucleophile: (1) 
a single concomitant step where the nucleophilic attack of µ–OH on the phosphate occurs 
as the OR leaving group is being protonated, (2) the µ–OH attack occurs before the 
protonation of the leaving group forming a pentacoordinate intermediate and (3) the 
protonation of the leaving group occurs before µ–OH attack. All three possibilities were 
attempted and the modeled catalytic mechanism was found to only occur in a single step 
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as shown in Figure 4.5. All attempts to form intermediates in the scenarios (2) and (3) 
resulted in collapses of the intermediate back to the RC or PC. 
	  
Figure 4.4 Pictorial representation of the reactant complex RC, transition state TS and 
product complex PC for DMP cleavage. Only the QM layer is shown with the 
catalytically relevant atoms enlarged. Atom colours, Red = O, Blue = N, Orange = P, 
Dark Yellow = S, Grey = C, White = H, Pale Yellow = general metal. 
Notably, the previous QM cluster studies on GpdQ and PAP yielded a pentacoordinate 
intermediate, scenario (2).25-26	   In both cases, the first step was rate limiting and the 
energy profiles showed the metastable intermediate almost equivalent to the barrier for 
the proceeding proton transfer.25-26 Notably, a one step mechanism is supported in the 
literature when the leaving group is stabilized.36-37 Therefore, we can hypothesize that the 
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inability to find a metastable pentacoordinate may be due to the QM/MM model holding 
His81 close to the leaving group, greatly stabilizing it. Repetition of the three remaining 
metals (Co(II)/Co(II), Mn(II)/Mn(II) and Cd(II)/Cd(II)) did not produce these 
intermediates therefore only the concerted mechanism was modeled throughout. 
Daumann et al. has shown experimentally that when Zn(II)/Zn(II), Co(II)/Co(II), 
Mn(II)/Mn(II) and Cd(II)/Cd(II) are placed in the active site, the catalytic rates kcat for the 
phoshodiester bpNPP was 0.11, 1.62, 4.86 and 15.0 s-1 respectively.19 The calculated 
barriers for the modeled µ–OH attack for each method and metal are shown in Table 4.1. 
It should be noted that the Mn(II)/Mn(II) transition state using M06L was located in a 
saddle point, as indicated by a frequency calculation, however it would not fully 
converge thus a reasonable approximation of the transition state is provided. The hybrid 
functional B3LYP and B3LYP* gave generally higher barriers than the meta-GGA 
functional M06L and hybrid-meta GGA functional MPW1BK. This is consistent with the 
previous study performed on PAPs.25 Interestingly, the barriers closely or in some cases, 
exactly followed the ordering of the experimental trend. This occurred in B3LYP*, M06 
and MPW1BK. Unfortunately the proportionality of the calculated barriers between each 
metal is difficult to quantitatively compare to the value of the kcat due to the inability to 
determine exactly how much of the enzyme contained homonuclear compositions vs. 
heteronuclear.19 Therefore comment of the performance must be done with caution.. 
Ultimately, if modeling DMP is representative enough of bpNPP cleavage and it does 
undergo the proposed mechanism, we can suggest that either the hybrid meta-GGA M06 
and MPW1BK functional or the hybrid B3LYP* functional produced barriers that are 
best in agreement with the experimental results. 
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Table 4.1. The transition state energies calculated for the hydrolysis of DMP for the four 
metals combinations using five different exchange-correlation functionals.  
 
B3LYP B3LYP* M06 M06L MPW1BK 
Zn(II)/Zn(II) 118.7 112.2 107.7 97.9 97.9 
Co(II)/Co(II) 122.5 101.4 96.3 86.2 66.1 
Mn(II)/Mn(II) 81.5 74.1 74.9 75.1* 48.5 
Cd(II)/Cd(II) 69.0 64.4 64.7 71.3 30.6 
*An approximate TS value 
4.3.2 DMP Binding to Form the Reactive Complex 
To begin the investigation of elucidating the source of the metal-dependent rate 
enhancement we examined the reactive complex (RC) structural parameters. The binding 
to the β metal varied significantly depending on the metal and functional used. For 
example, from Zn(II)/Zn(II), Co(II)/Co(II), Mn(II)/Mn(II) to Cd(II)/Cd(II) the 
phosOβ…Mβ decreases from 4.16 Å, 4.09Å, 3.10 Å and 2.56 Å respectively with B3LYP, 
3.48, 3.45, 3.09 and 2.56 with B3LYP*. However with the Truhlar functionals, the 
binding is more consistent regardless of the metal of interest with no obvious ordering; 
recording averages of 2.39 +/- 0.045 Å, 2.36 +/- 0.052 Å, 2.56 +/- 0.036 Å and 2.47 +/- 
0.019 Å for Zn(II)/Zn(II), Co(II)/Co(II), Mn(II)/Mn(II) and Cd(II)/Cd(II) respectively 
(Table 4.2). Therefore for Zn(II)/Zn(II), B3LYP and M06, for example, have a 1.72 Å 
discrepancy in binding strength between them. A second observation is that the 
rphosOα…Mα interaction is generally stronger than the phosOβ…Mβ interaction indicated 
by the shorter bond lengths with the exception of Cd(II)/Cd(II) whereas µ–OH is bound 
consistently stronger to the Mα, that is, Mα…µ–OH is smaller in the case of 
Zn(II)/Zn(II), Co(II)/Co(II) and Mn(II)/Mn(II) and in the case of Cd(II)/Cd(II) it is 
equidistant between the two (Table 4.3). 
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This highlights a consequence of single functional analysis. For example, by looking 
at just the B3LYP and B3LYP* functionals, phosOβ…	  Mβ appears to follow the energy 
trends. The phosOβ…Mβ length using B3LYP for Zn(II)/Zn(II), Co(II)/Co(II), 
Mn(II)/Mn(II) and Cd(II)/Cd(II) was 4.16 Å, 4.09 Å, 3.10 Å and 2.56 Å, and the 
associated energy barrier are 118.7, 122.5, 81.5, 69.0 kJ mol-1 and for B3LYP*, 3.48, 
3.45, 3.09 and 2.56 Å yielded 112.2, 101.4, 74.1, 64.4, 54.5 kJ mol-1. This could lead to a 
hypothesis that by binding to two Lewis acids, the phosphate would be more polarized 
and thus more susceptible to nucleophilic attack by µ–OH. Furthermore, it could be stated 
that the substrate binding of Cd(II)/Cd(II) and Mn(II)/Mn(II) mimics more of the 
transition state structure than Zn(II)/Zn(II) and Co(II)/Co(II), reducing the energy gap 
between them. However, by including more functionals in the study such as M06, M06L 
and MPW1BK this hypothesis cannot explain the source of catalytic activity because 
these functionals predict the same relative energy trends in the absence of those structural 
features. This indicates that there are more factors that are contributing to catalysis.  
4.3.3 DMP Transition State Structural Parameters 
Overall, unlike the RC, the general structures of the TS appear to be more consistent 
across all functionals for each metal. In phosphate hydrolysis, in general, there are two 
definitions of SN2(P) type reactions to describe the transition state: associative and 
dissociative.38-40 If the degree of bond cleavage phosOR…phosP is greater than the degree of 
bond formation (P…µ–OH) then the resulting net loss in bond order means the transition 
state has dissociative character.38-39 In contrast, if the P…µ–OH comes together before 
cleavage then it is denoted an associative mechanism. It has been determined using the 
kinetic isotope effect that phosphodiester in solution utilize a concerted associative 
transition state.36 This has energetic implications because it is thought the dissociative is 
predicted to be up to 1000-fold faster than the associative pathway.38  
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With this knowledge, we explored the possibility that the larger metals, Mn(II)/Mn(II) 
and Cd(II)/Cd(II) may be increasing the proton transfer component to enhance the rate of 
reaction. To test this hypothesis, the bond distances in the transition state particularly the 
distance of phosOR…phosP and His82-H…phosOR can be examined, Table 4.2. In theory, an 
increase in phosOR…phosP would decrease the bond order and shift to be a slightly more 
dissociative. This is observed where phosOR…phosP averages about 1.90 for Zn(II)/Zn(II) 
and Co(II)/Co(II), 1.92 Å for Mn(II)/Mn(II) and 1.94 for Cd(II)/Cd(II) in correlation with 
the rates/barriers. Consequently, the proton from His81 is consistently closer to the OR 
leaving group, by about 0.02 Å closer for Cd(II)/Mn(II) than it is for Zn(II)/Co(II) which 
stabilizes the leaving group Table 4.2.  
Additional transition state parameters include the phosOβ…Mβ length ranges from 
about 2.20 Å to 2.38 Å from Zn(II)/Zn(II) to Cd(II)/Cd(II). The phosOα…Mα interaction is 
stronger for each metal with Zn(II)/Zn(II) and Co(II)/Co(II) being 2.05–.10Å, 
Mn(II)/Mn(II) about 2.15 Å and Cd(II)/Cd(II) 2.31 Å. Similar to the RC, theμ-OH is 
shifted closer to the Mα than the Mβ for all metals. For Cd(II)/Cd(II) and Mn(II)/Mn(II) 
the hydroxyl more centered than for Zn(II)/Zn(II) and Co(II)/Co(II), Table 4.2 
4.3.4 Metal Induced Phosphate Strain  
Gherib et al. suggested that phosphate strain was a possible reason for the different 
rates among metals, specifically for Cd(II)/Cd(II). A size-dependent theory is possible 
because the ionic size does generally follow the trend of the experimental observed rates, 
albeit not proportional. For instance, the ionic radii of M+2 in an octahedral complex are 
74, 74.5, 83, 95 pm for Zn(II), Co(II), Mn(II), and Cd(II) respectively.41 Looking at the 
Mα…Mβ separation, it is clear that due to their size Zn(II)/Zn(II) and Co(II)/Co(II) are 
closer together averaging 3.07 +/- 0.02 Å and 3.09 +/- 0.02 Å respectively, Mn(II)/Mn(II) 
and Cd(II)/Cd(II) are further apart at 3.15 +/- 0.01 Å and 3.28 +/- 0.03 Å respectively 
(Table 4.3). Surprisingly, Cd(II)/Cd(II) being furthest apart did not lead to increase in 
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∠(phosOα–P–phosOβ), in fact for the RC, the ∠ (phosOα–P–phosOβ) angle is the smallest, 
averaging 116.2° and there is no distinct trend between the ∠(phosOα–P–phosOβ) and Mα…	  
Mβ. To compare the natural structural parameters of DMP in solution, absent of the 
active site, DMP was optimized using an IEFPCM solvation representative of water at the 
M06/6-31G(d) level of theory. This resulted in a much larger ∠(phosOα–P–phosOβ) of 
125.9°. For a direct comparison, looking at the M06 calculations in the active site was 
116.2°, a difference of 9.5° (Table 4.3). A single point calculation of both phosphates 
showed that the enzyme destabilizes the substrate by 39.9 kJ mol-1, illustrating reactant 
destabilization by angle compression. For the remaining metals, Zn(II)/Zn(II), 
Co(II)/Co(II) and Mn(II)/Mn(II), averages are similar of 116.6°, 116.8° and 117.6°  
making a difference of 9.1°, 8.9° and 8.1° respectively. This provides an explanation of 
how enzymes can significantly enhance reaction rates over un-catalyzed reactions but 
cannot be the source of the fine-tuning. 
The transition state bond angles averages may provide a portion of the fine-tuning. 
During the transition state, the phosOα…Mα and phosOβ…Mβ bond lengths decrease 
significantly along with the large increase in the Mα…Mβ distance, Table 4.3. At this 
point, the phosphate/metal interaction appears to be strong enough systematically 
influence ∠ (phosOα–P–phosOβ). The relative energies between transition states were 
approximated by single point calculations with ε=4. Referenced against Zn(II)/Zn(II)’s 
TS, the relative energy of Mn(II)/Mn(II), Co(II)/Co(II) and Cd(II/Cd(II) are more stable 
by 3.1, 3.0 and 11.0 kJ mol-1 respectively. This correlates with the ∠( phosOα–P–phosOβ) 
for Cd(II)/Cd(II), averaging 122.6° +/- 0.7° and Mn(II)/Mn(II), Co(II)/Co(II) and 
Zn(II)/Zn(II) from largest to smallest with 121.5 +/- 0.4°, 121.1+/- 0.4° and 120.9 +/- 
0.3° respectively (Table 4.3).  
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Table 4.3. The metal separation in the active site of GpdQ in Angstroms (Å) and 
phosphate angle in degrees (°). 
Zn(II)  r(Mα-Mβ) ∠ (phosOα…P…phosOβ) 
RC TS PC RC TS PC 
B3LYP 3.04 3.50 3.87 117.7 121.2 115.9 
B3LYP* 3.08 3.49 3.87 117.7 121.2 116.0 
M06 3.07 3.45 3.85 116.0 120.6 117.0 
M06L 3.08 3.45 3.85 116.2 121.2 118.9 
MPW1BK 3.07 3.49 3.86 115.6 120.5 117.3 
Co(II) RC TS PC RC TS PC 
B3LYP 3.06 3.46 3.76 117.8 121.8 116.3 
B3LYP* 3.09 3.49 3.75 118.0 120.9 116.5 
M06 3.09 3.42 3.72 115.9 121.1 116.8 
M06L 3.12 3.43 3.75 116.5 121.0 120.0 
MPW1BK 3.10 3.44 3.77 115.7 120.9 118.9 
Mn(II) RC TS PC RC TS PC 
B3LYP 3.16 3.52 3.90 117.8 122.0 116.0 
B3LYP* 3.15 3.52 3.91 117.9 121.9 116.3 
M06 3.15 3.49 3.84 116.8 121.1 118.1 
M06L 3.14 3.53 3.83 118.4 121.1 119.5 
MPW1BK 3.13 3.52 3.89 117.4 121.3 116.5 
Cd(II) RC TS PC RC TS PC 
B3LYP 3.31 3.61 4.16 116.2 123.3 117.4 
B3LYP* 3.31 3.61 3.91 116.3 123.4 118.7 
M06 3.27 3.59 4.10 116.2 122.2 118.0 
M06L 3.27 3.62 3.88 116.4 122.0 121.3 
MPW1BK 3.26 3.64 3.93 115.9 122.0 119.7 
 
4.3.5 Natural Bond Order (NBO) Analysis 
NBO calculations have been shown to be effective at estimating rate enhancement in 
phosphate cleavage reactions.39,42 This can help to explain if the particular metals 
polarizes the substrate to facilitates catalyst. The natural partial charges of oxygen of the 
nucleophile O(H), phosphorus P, leaving group OR two binding oxygens phosOα, phosOβ 
and both metal Mα and Mβ are shown in Table 4.4. These results were roughly compared 
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to a similar concerted mechanism of the cleavage of the RNA analogue (HpPNP) who 
compared Zn(II)/Zn(II) mediated cleavage vs. uncatalyzed reaction.42 They showed the 
NBO charge of the phosphate in the TS increased from +2.48 to +2.61, from uncatalyzed 
to catalyzed coupled with the build up of charge of both the nucleophile and the leaving 
group.42 If the catalyzed reaction is many folds faster than the uncatalyzed, then changes 
in these parameters may enhance the reaction.  
In agreement with their Zn(II)/(II) assisted mechanism,42 the natural charges of our 
phosphate center are around +2.60. The natural charges of the metals increases in positive 
charge where Co(II) < Mn(II) < Zn(II)  ≈ Cd(II), Table 4.4. This has large impact on the 
μ-OH in the RC and TS. The natural charge of µ–OH averages in the RC -1.08, -
1.11, -1.25 and 1.23 Co(II)/Co(II), Mn(II)/Mn(II), Zn(II)/Zn(II), Cd(II)/Cd(II) 
respectively. Furthermore, in the TS they are -1.02, -1.04, -1.08 and -1.09 of 
Co(II)/Co(II), Mn(II)/Mn(II), Zn(II)/Zn(II), Cd(II)/Cd(II) respectively. Here there is a 
relationship between the metals natural charge and build up of charge on the µ–OH. The 
positive charge is not greatly affected, indicated by a decrease of 0.01 following that 
same series. Surprisingly, we do not see a build up of negative charge on the leaving 
group from the increase µ–OH but we speculate that this may due to the proton 
neutralizing this charge where in their study a proton source was not present. 
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Table 4.4. NBO calculated natural charges for both reactant complex (RC) and transition 
state structures (TS). 
Zn2+ B3LYP B3LYP* M06 M06L MPW1BK 
RC TS RC TS RC TS RC TS RC TS 
O(H) -1.25 -1.07 -1.24 -1.07 -1.25 -1.09 -1.25 -1.09 -1.27 -1.09 
P 2.60 2.59 2.57 2.56 2.65 2.65 2.61 2.60 2.68 2.69 
OR -0.88 -0.84 -0.87 -0.83 -0.89 -0.83 -0.87 -0.84 -0.90 -0.87 
Oα -1.16 -1.19 -1.14 -1.17 -1.16 -1.21 -1.14 -1.19 -1.17 -1.23 
Oβ -1.14 -1.20 -1.12 -1.19 -1.15 -1.22 -1.15 -1.21 -1.17 -1.24 
Mα 1.40 1.40 1.38 1.39 1.39 1.40 1.42 1.43 1.41 1.42 
Mβ 1.40 1.39 1.38 1.37 1.38 1.39 1.41 1.42 1.40 1.41 
Co2+ RC TS RC TS RC TS RC TS RC TS 
O(H) -1.05 -1.01 -1.04 -1.00 -1.08 -1.03 -1.08 -1.02 -1.14 -1.05 
P 2.57 2.60 2.57 2.57 2.66 2.65 2.61 2.61 2.69 2.70 
OR -0.88 -0.83 -0.87 -0.83 -0.89 -0.86 -0.88 -0.84 -0.90 -0.87 
Oα -1.11 -1.09 -1.10 -1.11 -1.12 -1.15 -1.11 -1.13 -1.14 -1.18 
Oβ -1.15 -1.13 -1.12 -1.14 -1.14 -1.18 -1.12 -1.16 -1.15 -1.20 
Mα 1.14 1.12 1.07 1.05 1.08 1.09 1.11 1.11 1.16 1.16 
Mβ 1.10 1.10 1.06 1.05 1.08 1.11 1.12 1.12 1.16 1.17 
Mn2+ RC TS RC TS RC TS RC TS RC TS 
O(H) -1.11 -1.04 -1.09 -1.03 -1.10 -1.05 -1.08 -1.04 -1.14 -1.07 
P 2.58 2.59 2.55 2.56 2.63 2.65 2.58 2.60 2.66 2.69 
OR -0.89 -0.84 -0.88 -0.83 -0.89 -0.86 -0.89 -0.84 -0.91 -0.87 
Oα -1.13 -1.14 -1.11 -1.13 -1.14 -1.17 -1.12 -1.15 -1.15 -1.19 
Oβ -1.12 -1.17 -1.11 -1.15 -1.14 -1.18 -1.12 -1.17 -1.15 -1.21 
Mα 1.21 1.20 1.17 1.16 1.17 1.16 1.17 1.19 1.24 1.25 
Mβ 1.20 1.21 1.16 1.18 1.17 1.18 1.18 1.20 1.24 1.27 
Cd2+ RC TS RC TS RC TS RC TS RC TS 
O(H) -1.23 -1.09 -1.22 -1.08 -1.24 -1.10 -1.23 -1.10 -1.26 -1.10 
P 2.59 2.58 2.57 2.55 2.64 2.64 2.60 2.59 2.67 2.68 
OR -0.88 -0.84 -0.87 -0.83 -0.89 -0.86 -0.88 -0.84 -0.90 -0.87 
Oα -1.13 -1.18 -1.12 -1.17 -1.15 -1.20 -1.14 -1.18 -1.17 -1.23 
Oβ -1.15 -1.19 -1.13 -1.18 -1.16 -1.21 -1.14 -1.20 -1.17 -1.24 
Mα 1.41 1.44 1.39 1.42 1.41 1.44 1.43 1.47 1.45 1.48 
Mβ 1.41 1.43 1.39 1.41 1.41 1.44 1.43 1.46 1.45 1.47 
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To summarize, the characterization of mechanistic and structural parameters have led to 
several possibilities to enhance catalysis with the different metals combinations.  
• Cd(II)/Mn(II) shift the underlying mechanism more towards the dissociative 
mechanism over the associative than Zn(II)/Co(II) illustrated by the increase in 
phosOR…phosP and decrease in His82-H…phosOR stabilizing the leaving group. 
• Reactant destabilization by phosphate angle strain activates the phosphate for 
enzymatic catalysis. This would reduce the barrier of reaction for Cd(II)/Cd(II) 
over the uncatalyzed reaction by 39.9 kJ mol-1. 
• Transition state stabilization via phosphate angles contributes a small degree to 
fine-tuning up to 11 kJ mol-1. 
• The natural charges of the metals strongly influence the negative charge on the 
µ–OH enhancing its nucleophilic ability.	  
	  
4.3.6 Substituting Calcium Ions for Mα  and Mβ   
To test our theory that was built from examining the first four metals, Ca(II)/Ca(II) 
homonuclear compositions were used to examine any similarities and differences. 
Octahedral Ca(II) has a ionic radii of about 100 pm making it marginally larger than 
Cd(II) ~5 pm.41 The structural parameters of interests are shown in Table 4.5. The larger 
ionic radii continues to widen the active site indicated by an Mα-Mβ in the RC of about 
3.40 Å (up from about 3.30 Å in Cd(II)). For the first four metals, the increase in Mα-Mβ 
correlated with the decrease in ∠(phosOα–P–phosOβ). This was observed in Ca(II)/Ca(II) as 
well with an ∠ phosOα–P–phosOβ of 115.3°. This difference was quantified by preforming 
single point calculations on DMP and compared the results with the DMP of 
Cd(II)/Cd(II). The calculated relative energy difference was +12.1 kJ mol-1 higher for 
Ca(II)/Ca(II) than Cd(II)/Cd(II). Remarkably, the phosphate strain is becoming large 
enough that a small change of about one degree causes 10+ kJ mol-1 destabilization of the 
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reactant. The calculated barrier between Cd(II)/Cd(II) and Ca(II)/Ca(II) for M06 was 
about 6 kJ mol-1. The transition state structure stabilization was also quantified, the 
difference was minimal; 1.35 kJ mol-1 less stable than Cd(II)/Cd(II). Therefore, it is likely 
that reactant destabilization is accounting for the majority of the enhanced rate predicted 
by DFT calculation. 
Table 4.5. Select parameters of the Ca(II)/Ca(II) derivative. 
Ca(II) 
Barrier 
kJ mol-1 
r(Mα-Mβ) 
∠ phosOα  - P - 
phosOβ   
His82-H 
…phosOR 
phosOR
…P 
RC TS RC TS TS TS 
B3LYP 59.7 3.43 3.70 115.1 124.0 1.26 1.94 
B3LYP* 54.5 3.43 3.69 115.1 124.0 1.26 1.94 
M06 59.0 3.38 3.75 115.6 122.3 1.33 1.87 
M06L 42.3 3.40 3.76 115.5 122.1 1.31 1.90 
MPW1BK 42.6 3.38 3.73 115.1 122.5 1.25 1.88 
It is important to note that binuclear serum paraoxonase-1 (PON) found in humans 
(PBD: 3SRE) use catalytic calcium in its active site.43-44 Notably, the name paraoxonase 
comes from its ability to degrade the organophosphate paraoxon.43 The surround residues 
around the metals differ from GpdQ,43 it would be interesting to design active site in 
GdpQ that would utilize calcium due its low toxicity in high concentrations and good 
tolerance towards air and moisture.  
4.3.7 Mα-ligand Substitutions for Homonuclear Cd(II)/Cd(II) 
Here we show preliminarily data on the result of mutating the surrounding ligands 
around the α-ligands as this may affect the rate of phosphate cleavage. We tested single, 
double and triple mutations on the Mα switching aspartate with histidine and vise versa 
Figure 4.4. Out of the seven variants tested, only two had a stable RC. Unfortunately, 
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none had a barrier that was less than the calculated wild type (Table 4.5). It is interesting 
to note we see that the difference in barrier do, in general, correspond to the strain in the 
RC. This is consistent to what we shown is a major factor in rate enhancement from the 
Zn, Co, Mn, Cd and Ca series. The barriers calculated were 73.6 (WT), 85.3 (H8D) and 
94.9 kJ mol-1 (D10H, D197H) and had ∠ phosOα–P–phosOβ angles of 118.8°, 121.1° and 
120.1° respectively. The difference in the latter two may be explained by the overstretch 
of the TS of 127.6° and 129.7 
	  
	  
Figure 4.5. Pictorial representation of the substitution on the Mα-site. Blue font colour 
represents the change from the wild type (top).  
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Table 4.6 Selected parameters in the Mα substituted ligands. 
Substitution 
Relative 
TS 
Energy 
(kJ mol-1)  
∠ phosOα - P - 
phosOβ ( ° ) Comment 
RC TS 
WT 73.6 118.8 126.9 
	  H8D 85.3 121.1 127.6 
	  D197H    Not fully optimized 
D10H, D197H  94.9 120.1 129.7 
	  H8D, D10H, 
D197H N/A N/A N/A 
Histidine 
uncoordinated from Cd 
 
D10H N/A N/A N/A 
Asp10 abstracts a 
proton from His81; No 
longer an acid 
 
H8D, D10H  N/A N/A N/A 
Phosphate does not 
bind to α metal 
 
H8D, D197H  N/A N/A N/A 
Collapses to PC due to 
Asp8 polarizing µ-OH 
making it a potent 
nucleophile 
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4.4 Conclusions 
Herein we explored the µ–OH directed mechanism in homonuclear 
Glycerophosphodiesterase (GpdQ). The mechanism was found to occur in a single step 
with the concomitant nucleophilic attack and protonation of the leaving group. The 
ordering of the calculated barriers was in general agreement for all functionals and exact 
for B3LYP*, M06 and MPW1BK.  
The driving force behind the mechanism was explored. The reactivity of GpdQ over 
uncatalyzed reactions can be contributed greatly to reactant destabilization. It was 
calculated that the strain of phosphate indicated by a compressed ∠( phosOα–P–phosOβ) 
activates the substrate. For Cd(II)/Cd(II), Zn(II)/Zn(II), Co(II)/Co(II) and Mn(II)/Mn(II), 
the averages ∠( phosO–P–phosOβ)  is 116.2, 116.6, 116.8 and 117.6 making a difference for 
DMP in water of 9.5, 9.1°, 8.9° and 8.1° respectively. For Cd(II)/Cd(II), reactant 
destabilization was calculated to be 39.9 kJ mol-1. 
The source of the fine-tuning between the metals was also explored. First, it was 
hypothesized that Cd(II)/Cd(II) and Mn(II)/Mn(II) may stabilize the leaving group of the 
transition state. This was characterized by a systematic increase in phosOR…phosP in the 
transition states complexes coupled with a decrease in His82-H…phosOR. Furthermore, due 
to the increase in ionic radii between the metals, the strong interactions between the 
phosphate and the metals then stretched the transition state. The relative energy of 
difference contributed to the TS ∠( phosOα–P–phosOβ) was compared to Zn(II)/Zn(II) 
structure. It was found that Mn(II)/Mn(II), Co(II)/Co(II) and Cd(II/Cd(II) are more stable 
by 3.1, 3.0 and 11.0 kJ mol-1 respectively. 
A Ca(II)/Ca(II) derivative was explored in an attempt to extrapolate the previous 
results in to a larger metal. It was found that reactant destabilization dictated the lower 
barrier. A ∠ phosOα–P–phosOβ of 115.3° contributed to a 12.1 kJ mol-1 increase in energy 
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over Cd(II)/Cd(II). Finally, we attempted to increase the rate of reaction by substituting 
ligand on Mα-site. Unfortunately, none of the mutation resulted in a barrier lower than 
the wild type however ∠ phosOα–P–phosOβ angle did agree with our previous predictions.  
Overall, we provide several contributing factors to metal dependent phosphate 
hydrolysis in GdpQ. Future studies must now revisit the terminal water mechanism to 
determine if it is competitive with the mechanism shown in this study.  
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5.1 Introduction 
The increasing frequency of antibiotic resistance bacteria is perhaps one of the greatest 
health related challenges of this century.1 This has been magnified due to the 
overuse/misuse of antibiotics dating back to when penicillin mass production was first 
made possible in the 1940s.2-3 This is problematic because antibiotics are vital to combat 
infections in endless medical procedures from surgery to cancer chemotherapy.1,4 In 
addition, there is also an astonishing economic consequence, for example it cost both 
Europe5-6 and the United States7 several billion dollars annually.8 In result, there is an 
urgency to react. 
One of the main modes of antibiotic resistance is through the class of enzymes known 
as β-lactamases.9 Bacteria have an enzyme that has glycosyltransferase and 
transpeptidases activity called penicillin binding proteins, PBPs that are responsible for 
the construction of cell walls.10-11 PBPs are a bacterial specific target for antibiotics 
because eukaryotes do not have cell walls.10 β-lactam antibiotics, in particular, function 
by inhibiting specifically the transpeptidases activity of PBPs.10 Unfortunately, bacteria 
then counter this inhibition via β-lactamases that hydrolyze the β-lactam ring before it 
can perform its function. Collectively, there are four different classes of β-lactamases by 
the Ambler classification system that places them, based on there sequence, in classes A 
through D.12 Classes A, C and D are mechanistically similar as they are serine driven 
hydrolases. Class B enzymes are the exception as they are metallo-β-lactamases 
(MBL).12-13 
Interest here is in the TEM-1 class A β-lactamase. It is well characterized due to its 
high frequency in infections therefore its mechanism has been extensively studied.14-19 
The mechanism can be summarized into two half reactions: acylation and hydrolysis/ 
deacylation. In the former, Ser70 is acylated by the β-lactam’s carbonyl carbon. This 
occurs through the formation of an unstable oxyanion that is stabilized by an “oxyanion 
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pocket” that is composed of the backbone hydrogen bonds from Ala237 and Ser70.19 
However, how this oxyanion itself is formed has been greatly debated. There have been 
three different proposals for the general base for this step.18, 20-21 First, Lys73 is proposed 
to act as the catalytic base to activate Ser70 for nucleophilic attack.21 Second, a substrate-
assisted mechanism has been proposed by Díaz et al.18 Finally, Glu166 has been 
proposed as the mechanistic base either directly deprotonating Ser70 or indirectly 
through a conserved water.18-19 It is important to note that it is likely that the enzyme 
could undergo all the aforementioned pathways because site-directed mutagenesis of 
Lys73, Glu166 or both only reduces acylation activity.22-23 In contrast to the first step, the 
second step is not generally debated. The deacylation of the substrate is facilitated by a 
conserved water using Glu166 to release the product.24 
	  
Figure 5.1. The proposed mechanism for the acylation step with Glu166 as the catalytic 
base. A) Activation of serine B) the unstable tetrahedral intermediate C) Protonation of 
amine and ring opening D) Acyl-enzyme.25 
Currently, there are four commercially available β-lactamases inhibitors: clavulanic 
acid, sulbactam and tazobactum and most recently avibactam Figure 5.1. They all have 
the β-lactam functional group with the exception of avibactam.26 They are reasonably 
effective against class A and to a lesser extent against class C.27-28 A strategy that has 
been proven to work is to combine β-lactamase inhibitors with β-lactam antibiotic to 
enhance potency.29 For example, clavulanic acid matched with amoxicillin, sulbactam 
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with ampicillin, and tazobactam with piperacillin are all approved for use in the U.S.A.27 
As time progresses, mutations have allowed β-lactamases to confer more resistance to 
these cocktails and it is important to continually be innovating new strategies.30 
	  
Figure 5.2. The four currently approved β-lactamases inhibitors and the most promising 
boronic acid inhibitors. 
One strategy that has recently received increased attention is revisiting the use of 
boronic acid transition state inhibitors (BATSIs).31 In principle, BATSIs are 
advantageous mainly due to two chemical properties of boron (1) when in its neutral 
form; an empty p-orbital is present that is a strong Lewis acid. (2) The resulting 
intermediate mimics a more stable version of the original β-lactam transition state 
complex.32  Interestingly, very little is known about boron in therapeutics mostly because 
there is very few naturally occurring boron containing compounds.32 This may be due 
that the fact that many antibiotics are often modeled after natural substrates and the 
synthetic methods to build complex organic boron containing molecule are not as 
advanced. 
The most common type of boron-containing β-lactamases inhibitors are derivatives of 
boronic acid.33-35 The pKa often fall between 8-10 therefore they are three-coordinated 
and pronated at physiological pH.36 Notably, boronic acids are susceptible to reversible 
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nucleophile attack in water therefore they are in an equilibrium between the anionic and 
natural state. Currently, most boronic acid antibiotics are in its discovery stage (Pre phase 
1 trial) however there is one combination of carbapenem/boronic acid that is currently in 
phase II trial.37 RPX7009 (Figure 5.2) is a very promising β-lactamase inhibitor with 
activity against serine carbapenemase.13,38  
Computational chemistry allows for the determination of different functional groups 
that would be difficult to synthesize experimentally to gain knowledge about its 
fundamental properties. This allows for cost friendly way to rationally design new 
inhibitors. In this study, we explored the thermodynamic stability of the boron inhibition 
pathway benchmarked against a common antibiotic, benzylpenicillin. 
 
5.2 Computational Methods  
5.2.1 Molecular Docking and Molecular Dynamic Simulations 
 The crystal structure PDB ID: 1BTL39 from Class A Escherichia coli TEM1 high-
resolution 1.8 Å was used as the template for the investigation. First, the initial 
crystallographic data was prepared using the molecular operating environment (MOE) 
software by removing the waters and resolving the system.40 The structure was then 
allowed to relax using the AMBER12:EHT force field to remove any strain from the 
preparation of the protein structure. The substrate benzylpenicillin was then docked in its 
known active site19 using the induced fit formulism.40 The to evaluate the top poses, the 
London dG scoring function was used with the AMBER12:EHT force field refinement 
keeping the top 10 scores. The top structure that was oriented in a matter that correlated 
well with the known binding mode of benzylpenicillin was selected. A boron-substituted 
substrate was created by mutating the carbonyl carbon to neutral boron, which 
sequentially required the protonation of the adjacent oxygen (Figure 5.3). The substitute 
Chapter 5: Computational Insights into the use of Boron for Inhibiting β-lactamases 
89	  
	  
was then docked and scored to compare the relative binding mode. This hypothetical 
compound would allow for the testing of boron as a Lewis acid compared to the natural 
substrate with directly comparable binding orientations. 
	  
Figure 5.3. Comparative models of A) benzylpenicillin and B) boron substitute used in 
this study. 
Two one-nanosecond simulations were performed on both complexes to find a relaxed 
minimum energy conformation with the substrate present. In the MD simulation, all 
atoms were free to move and a time step of 2 fs was used. The Columbic interactions 
were calculated with the PME method and 8-10 Å were the upper limit cutoff for the van 
der Waals interactions. The system was first annealed with a temperature built from 150-
300 K and equilibrated for 100 ps. The production run was carried out at 300 K for 1000 
ps. An estimated average structure found in the production run was then selected and 
minimized with the AMBER12:EHT force field. This structure was the starting structure 
to build the QM/MM model.  
5.2.2 The QM/MM Model and Calculations. 
The quantum mechanical layer of the QM/MM model consisted of the full substrate; 
and truncated surrounding residues, Ser70, Lys73, Asn170, Glu166, Ser130, Lys234, 
Ala237, Gly236, and Arg244 for a total of 150 atoms. The molecular mechanics layer 
contained 2806 atoms that surrounded the QM layer. Atoms 10 angstroms from the 
boundary of the QM layer were free to move whereas all atoms beyond that point were 
fixed. The calculations were performed using the Gaussian 09 suite of programs.41 
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Optimizations were performed using the ONIOM formulism.42 The hybrid exchange 
functional B3LYP using the 6-31G(d, p) Pople basis set was used to calculate the QM 
atoms geometries and energies. The MM region was calculated using AMBER96 as 
implemented in Gaussian 09. This functional has been used previous when studying this 
system and results were comparable with experimental work.19, 25  
	  
Figure 5.4. Pictorial representation of the QM layer modeled in the study, the MM was 
excluded for clarity. Atom colours, Red=O, Blue=N, Yellow=S, Grey=C, White=H. 
 
5.3 Results and Discussion 
5.3.1 Selection of the Benzylpenicillin and the Boron Substitute  
The focus of this study was to make a single variable change to quantify the use of 
boron as a Lewis acid in serine protease reaction. In order to do this, two scenarios must 
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be achieved, (1) the system must be standardized to a well studied β-lactamases and its 
associated mechanism and (2) the binding must be very similar because this would have 
an effect on the thermodynamics of the mechanism.19 Experimentally, TEM-1 β-
lactamases have been found to strongly bind and cleave benzylpenicillin, kcat = 1200 s-1, 
Km = 22 µM, kcat/Km = 5.5 × 107 M-1 s-1.43 A small Km and a large kcat indicates that the 
structure of penicillin is optimal for TEM-1’s active site. Furthermore, there have been 
previous computational studies on benzylpenicillin19 and the similar penicillanic acid21 to 
provide a means to benchmark our model. Therefore, boron-substituted benzylpenicillin 
(Figure 5.4, B), was constructed where the boron was replaced the carbonyl of the amide 
in the lactam ring and the carbonyl was protonated. This model, in theory, would allow 
for direct comparison of the thermodynamics of the natural substrate with that of boron. 
Before this compound was studied in an enzyme environment, it was tested for general 
thermodynamic stability. Both the neutral and anionic form was optimized at the 
B3LYP/6-31G(d,p) level of theory and the anionic state was +10.1 kJ mol-1 higher in 
energy than the neutral form. Therefore in solution, it would be more favourable for this 
compound to be in the neutral state vs. the anionic state, which is consistent with the pKa 
determined for boronic acids.36 
5.3.2. Molecular Docking Analysis 
A molecular docking protocol was performed to both substrates in the active site 
before the molecular dynamic (MD) simulation. The dock was guided with the aid of 
previous computational work,19,21 by disregarding scores that did not bind 
benzylpenicillin correctly into the active site. The Gibbs free energy of benzylpenicillin 
corresponding to the top score, in the proper orientation, was -62.6 kJ mol-1. This large 
exergonic binding energy corresponds with the low kM value found in class A β-
lactamases.43 The dock protocol was then carried out on the boron substitute and the pose 
selected overlaid virtually identically with benzylpenicillin. Interestingly, the docking 
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score for the boron substitute was slightly greater at -66.5 kJ mol-1. This small difference 
may be due to the slightly stronger interaction between Arg244 and the carboxylic acid 
on the substrate.  
	  
Figure 5.5. An pictorial overlay of the docked structures of benzylpenicillin and the 
boron analogue. Atom colours: grey=C, red=O, blue=N yellow=S orange=B and 
white=H. 
 
5.3.3 Molecular Dynamic Analysis 
A one-nanosecond molecular dynamic simulation was performed on both docked 
models to allow the substrate to relax in the environment of the active site residues. Due 
to the nature of the mechanism, a few key interactions were recorded through the 
simulation, Table 5.1. First and foremost was the comparison between the electrophilic 
carbonyl carbon of penicillin and the nucleophilic oxygen of Ser70 vs. the analogous 
boron and Ser70 as this interaction is vital of the initiation of the mechanism. The 
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distances between C…OSer70 and B…OSer70 averaged 3.16 +/- 0.17 Å and 3.14 +/- 0.16 
Å respectively. Second, Ala237 has been shown to be important for the stabilization of 
the substrates oxyanion, therefore this interaction must be present to make the mechanism 
energetically feasible.21 As expected, there is a slightly stronger interaction between the 
benzylpenicillin’s carbonyl Ala237-H…O=C of 1.87 +/- 0.11 Å than the hydroxyl group 
on the boron analogue Ala237-H…O(H)B of 2.00 +/- 0.16 Å. However, it is clear that in 
both cases, the substrate fits directly in the pocket. Notably, in the boron-substituted 
model, the conserved water immediately leaves the active site and serine is strongly H-
bonded to Glu166, 1.36 Å apart.	  
Table 5.1. Key average distances obtained throughout the MD simulation. 
	  
Benzylpenicillin Boron-Substitute 
	  
Average 
Distance 
Standard 
Deviation 
Average 
Distance 
Standard 
Deviation 
Ala237-H…O-X* 1.87 0.11 2.00 0.16 
r(X…OSer70) 3.16 0.17 3.14 0.21 
r(Nsub…OSer130) 3.46 0.42 3.01 0.44 
*Where X is either the carbonyl carbon in benzylpenicillin or boron in the derivative 
5.3.4 Reproducing the Catalytic Mechanism of Benzylpenicillin 
Hermman and coworkers first performed a QM/MM study of the acylation half 
reaction of benzylpenicillin with Glu166 as the base.19 Meroueh and coworkers re-
evaluated that mechanism along with Lys73 as the catalytic base with penicillanic acid.21 
In both cases, the first acylation step was rate limiting followed by a rapid protonation of 
the nitrogen of the amide group to create the acyl enzyme. Here, we modeled the former 
with Glu166 as the base, acknowledging that both mechanisms could be competitive. 
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Figure 5.6. Key structural parameters for the acylation step of benzyl penicillin. The first 
part of the mechanism, the nucleophilic attack, is highlighted in red. The main atoms 
involved in the second part, the C-N cleavage are highlight in blue. All bond lengths are 
in Angstroms (Å). 
 The initial optimization of the reactive complex (PRC) from the MD simulation 
reduced C…OSer70 from 3.16 Å to 3.10 Å, Figure 5.4. A water (WATcat) molecule was 
found to remain in the active site, between Glu166 and Ser70 throughout the simulation. 
This water was found to be in a position that is optimal to act as a proton shuttle 
positioned 1.75 Å between HO-H…O(H)Ser70 and 1.81 Å from HO-H…OOC-Glu166. 
The activation of Ser70 has been shown to occur concomitantly with the nucleophilic 
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attack on the substrate whereas a step wise mechanism is not likely due to the formation 
of an unstable positively charged alcohol functional group.19 The concomitant reaction is 
shown in Figure 5.7 and is found to occur at a barrier of 92.6 kJ mol-1. This is comparable 
to the re-evaluation where the calculated mechanism of penicillanic acid first step was 
found to be 108.7 kJ mol-1.21 Furthermore, this is consistent with experimental results that 
show that penicillanic acid kcat to be 38 s-1 nearly a thousand-fold decrease from 
benzylpenicillin.43 This would predict a theoretical reduction of about 20 kJ mol-1 using 
the Arrhenius equation. 
 Stabilization of the transition state is achieved by both the backbone N-H of both 
Ala237 and Ser70 (Figure 5.6). The increase in negative charge on the carbonyl oxygen is 
inferred by the shortening of the hydrogen bond between PRC to PTS1 from 2.04 to 1.74 
and 3.83 to 2.26 Å for Ala237 and Ser70 respectively. The C…OSer70 length is 1.94 Å in 
PTS1 with both hydrogen atoms proportionately between Ser70 and WATcat, and WATcat 
Glu166 (Figure 5.6). This results in the formation of the metastable tetrahedral 
intermediate PIC1. This intermediate was found to be 48.3 kJ mol-1 higher than the PRC 
(Figure 5.7). The carbonyl double bond has lengthen, C–O is now 1.30 Å from 1.21 in 
the PRC. The oxygen is partially anionic that is stabilized by the backbone hydrogen 
bonds of Ala237 and Ser70 of 1.68 and 2.03 Å respectively. 
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Figure 5.7. Potential energy surface representing the acylation of benzylpenicillin in 
TEM-1. Atom colours: grey=C, red=O, blue=N and white=H. 
The second part of the acylation half reaction is to collapse the meta-stable tetrahedral 
intermediate by cleaving the carbon-nitrogen bond. Ser130 functions as a catalytic acid 
by protonating the nitrogen amide of the substrate. In a similar manner to the PTS1, 
Ser130 must receive a proton simultaneously with its deprotonation because anionic 
Ser130 would be unstable. The proton source has been proposed to be Lys73.19,21 
Interestingly, upon optimization Lys73 and Lys234 are both positioned in close proximity 
to do this task. Since PIC1 had Lys234 already strongly polarized to Ser130, it was used 
as the base in the reaction; either would be sufficient since its known not to be the rate-
limiting step. The proton transfer was found to occur at a low barrier of 26.4 kJ mol-1 
forming the acyl enzyme PIC2 Figure 5.7. Finally, the tetrahedral intermediate collapse 
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formed the acyl-enzyme (IC3) that was 83.3 kJ mol-1 more stable than the metastable 
PIC1 and overall -35 kJ mol-1 less than the PRC. This emphasizes the irreversibility and 
therefore the necessity of the second half reaction for β-lactamases, deacylation by 
WATcat whose mechanism is beyond the scope of this preliminary study. 
5.3.5 The Catalytic Mechanism of Boron Substituted Benzyl Penicillin 
The boron derivative was modeled using QM/MM in a similar manner to penicillin. 
However, as mentioned, there were key differences in MD average structure. As 
previously stated, the water left the active site pocket during the molecular dynamic 
simulation, which resulted in the Glu166 to be in close proximity to Ser70. This 
conformation has been observed before in TEM-1 as the Ω loop that contains Glu166 has 
been shown to have high flexibility and mobility.44 After optimization, the BRC had 
Ser70 strongly hydrogen bound to Glu166 with 1.80 Å separating the two moieties. It is 
important to note that there may be a direct energetic consequence due to this change. 
The pKa of water is greater than that of methanol (15.7 vs. 15.5) therefore the conjugate 
base of a carboxylic acid must abstract a proton through two moieties that are 
unfavourable to be deprotonated. Fortunately, Meroueh and coworkers also carried out 
the mechanism of Lys73 as the base where Lys73 (a stronger base than Glu166) directly 
abstracted a proton from Ser70. The difference between their Glu166 mechanism and 
Lys73 was about 17 kJ mol-1.21 This would roughly represent the upper and lower bound 
to direct proton abstraction and should be considered if directly comparing 
benzylpenicillin and boron’s mechanisms. 
Further examination the structural parameters calculated in the BRC showed that 
B…OSer70 lengthened slightly from the MD simulation from 3.16 to 3.24 Å Figure 5.8. 
The oxyanion pocket that consists of the backbone Ala237 and Ser70 still interacts with 
the hydroxyl group, Ala237-H…O(H)B distance was 2.21 Å. The B–N and B–O bond in 
the BRC was 1.44 Å and 1.35 Å. In contrast to benzylpenicillin’s mechanism, the first 
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transition state did not require the activation of serine. This occurred at a barrier of 36.4 
kJ mol-1 to yield an intermediate complex, BIC1 that lies 7.9 kJ mol-1 higher than the 
reactant, Figure 5.9. This is compared to the difference between the PRC and PTS and 
PRC and PIC1 of +92.6 and +48.3 kJ mol-1, Figure 5.7. This explicitly shows theoretical 
application of boronic acid transition state inhibitors (BATSIs) that mimic the tetrahedral 
transition state of the natural reaction but offers much higher stability in both the TS and 
IC. The electron density approaching the boron atom does increase the H-bonding in the 
pocket Ala237-H…O(H)B by 0.24 Å to 1.97 Å and also elongated the B–N bond by 0.05 
Å to 1.49 Å.  
BIC1 differs from PIC1 in that the Ser70 is positively charged (Figure 5.8). In BIC1, 
B…OSer70 distance is 1.68 Å, indicating a weak covalent/dative bond therefore boron is 
now tetrahedral and has a formal negative charge. The electrons from nitrogen lone pair 
can no longer semi-overlap with boron once empty p-orbital and we see that the B–N 
lengthens to 1.55 Å, a 0.11 Å increase from the BRC. The next likely step is the 
abstraction of the proton from Ser70. The Glu166 is in a moderately strong hydrogen 
bond distance from H-OSer70, 2.01 Å apart, and this abstraction was modeled as BTS2. 
In BTS2, the proton is positioned linearly between Glu166 and Ser70 of 1.26 Å and 1.18 
Å respectively, Figure 5.8. In BIC2, B-OSer70 is reduced to 1.49 Å. This is a much 
stronger bonding interaction that is comparable to the B–OH in the “oxyanion” hole that 
has lengthened of 1.46 Å Figure 5.8. The increase in electron density on boron increased 
B–N further to 1.64 Å.  
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Figure 5.8. Key structural parameters for the acylation step of benzyl penicillin. The first 
part of the mechanism, the nucleophilic attack, is highlighted in red. The main atoms 
involved in the second part, the C-N cleavage are highlight in blue. All bond lengths are 
in Angstroms (Å). 
The second part of the acylation half reaction is the protonation of the adjacent 
nitrogen group to cleave the B–N interaction, which is now completely analogous to 
benzylpenicillin. In the BIC2 optimized structure, Ser130 is already strongly hydrogen 
bonded to the nitrogen hydrogen acceptor of the substrate, separated by 1.63 Å, Figure 
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5.8. For direct comparison, we chose to use Lys234 to protonate Ser130 concomitantly 
with the protonated of the substrate’s nitrogen atom, BTS3. As with penicillin, this 
reaction is rapid in comparison to the rate-limiting step illustrated by a relative difference 
of only 4.0 kJ mol-1. The final intermediate, BIC3 has the proton completely transferred 
to the nitrogen, this lengthened the B–N distance to 1.75 Å. Surprisingly, the interaction 
did not break as in penicillin.	  
	   	  
Figure 5.9 Potential energy surface representing the acylation of benzylpenicillin in 
TEM-1. Atom colours: grey=C, red=O, blue=N and white=H. 
In an alternative pathway, we tested if after the BIC1 is formed, could the nitrogen be 
protonated before glutamate abstracts the proton from Ser70? The barrier of this process 
was 28.0 kJ mol-1 compared to the 16.3 kJ mol-1 of proton abstraction in the prior 
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mechanism. The following proton abstraction from Ser70 by Glu166 was only 4.4 kJ 
mol-1. This shows that once the tetrahedral complex is formed, it is likely that the proton 
is abstracted from serine followed by the protonation of nitrogen by Ser70. However 
these results show that both mechanisms are energetically feasible.	  
5.3.6 Implications of the Preliminary Results  
There are considerable difference between the acylation of the substrate through a 
carbonyl carbon and boron. In benzylpenicillin, the barrier was calculated to be 92.6 kJ 
mol-1 compared to 36.4 kJ mol-1 for boron. This can be partly attributed to boron having 
an empty p-orbital as well that Ser70 did not need to be activated prior to nucleophilic 
attack. In addition, the carbonyl must be stabilized by the oxyanion hole whereas the 
hydroxyl group does not require significant stabilization. While it is beneficial to have a 
low barrier for nucleophilic attack there is also consequences. One of the benefits of 
using β-lactams as an antibiotic inhibitor is that once formed, the reaction is not 
reversible. This is highlighted in the benzylpenicillin reaction potential energy coordinate 
(Figure 5.7). The energy difference between the PIC2, acyl-enzyme and the rate-limiting 
step is 127.6 kJ mol-1. This is would be difficult to overcome. In contrast, the difference 
between BIC3, acyl enzyme, and the rate-limiting step BTS1 is only 47.9 kJ mol-1. The 
potential energy curve is also much flatter in the case of boron making it much more 
reversible; this has been suggested and observed experimentally for boric acid 
derivatives.45 
 Although the second step of β-lactamases was not explicitly explored in this study 
inferences can be made because it well established.46 The consensus of this reaction is 
that Glu166 uses a conserved water to hydrolyze the Ser70-subtrated interaction. This is 
possible because the acyl enzyme has an electrophilic carbon susceptible to nucleophilic 
attack. In the case tetrahedral boron, nucleophilic attack cannot take place because it is no 
longer electrophilic and is formally anionic.28  
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Another major difference in the two mechanisms was the B–N bond did not break 
upon protonation. This is an interesting aspect that has potential implications as it is 
thought that cyclical boron variant would be more selective to β-lactamase as its pocket is 
designed to hold cyclic transition states and intermediates.28-29 Recently, a crystal 
structure of RPX7009 (Figure 5.2) was resolved in the active site of a Class A.29 This 
crystal structure suggests that Ser130 is in close proximity to the adjacent oxygen to 
boron in the 6-membered ring. This shows that cyclic boron derivatives are orientated 
similarly as 4-member β-lactam.  
Although this study uses the boron-nitrogen combination, its use in cells would be 
difficult. B-N bonds are generally not hydrolytically stable unless modifications are made 
to protect boron.47 1,2-azaborines, on the other hand, are water stable conjugated ring 
structures.48-49 Furthermore, the boron on 1,2-azaborines also has been shown to have 
electrophilic character and found to inhibit Enoyl reductase (ENR) in the same way as it 
would inhibit a serine protease.50-51 It would be interesting to test if a 1,2-azaborines 
analogue could properly bind to the active site of TEM-1 β-lactamase. 
 
5.4 Conclusions 
In this study, preliminary calculations were performed to investigate the effectiveness 
of using boron as a Lewis acid for the inhibition of class A TEM-1 β-lactamase. This was 
accomplished by comparing the well-characterized mechanism of benzylpenicillin/ 
penicillanic acid with a single variable change to make a cyclic boron substitute. This 
allowed for the quantification of using boron as a Lewis acid in a serine protease type 
reaction.  
In the control acylation of TEM-1 with benzylpenicillin, the rate limiting first step was 
the nucleophilic attack of Ser70 on the substrate with a calculated barrier of 94.5 kJ 
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mol-1. This was compared and found to be consistent with previous work on this 
enzyme.21 This validated that the QM/MM model was satisfactory to quantify the boron 
substitute. The 4-member hypothetical compound conferred virtually identical binding to 
the TEM-1 active site as confirmed by molecular docking and molecular dynamic 
simulation. The rate-limiting step for the nucleophilic attack on boron was substantially 
less than that of β-lactam, a barrier of 36.4 kJ mol-1. The nature of the mechanism shows 
why the barrier is lower, that is, Ser70 did not need to be activated in order to covalently 
bind to the substrate nor did it form an oxyanion intermediate. This exemplifies the 
power of using a transition state analogue. A second major difference is in the second 
part of the first half reaction. In benzylpenicillin, this step causes the cleavage of the 
amide bond whereas in the boron analogue, the B–N bond elongates but stays intact. This 
has mechanistic consequences for the second half reaction the deacylation. A water 
molecule would not be able to cleave the “acyl-enzyme” effectively halting the second 
half reaction.  
However, the major drawback to using boron as an inhibitor is its reversibility. This 
has now been quantified where the potential energy of the reverse reaction, going from 
the acyl enzyme and the rate-limiting step, is only 47.9 kJ mol-1 apart. This can be 
compared to benzylpenicillin that would have to overcome a much larger barrier of 127.6 
kJ mol-1. Future work requires stabilizing the structure of the “acyl-enzyme” complex to 
minimize the reversibility. This may be aided by the recently published crystal structure 
of the cyclic RPX7009 bound in the active site of a class A and class C β-lactamase 
reveling of a 6-member ring would orientate itself in the active site.29 
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6.1 Conclusions 
In this thesis, several computational methods have been used to investigate properties 
of various enzymes and intermediates. In particular, we investigated 3– and 4–
coordinated sulfur intermediates that have been proposed/shown to occur in biological 
systems. Furthermore, we investigated two catalytic mechanisms (1) the 
phosphodiesterase activity in GpdQ and (2) the hydrolysis activity of TEM-1 β-lactamase 
with emphasis on its inhibition.	  	  
In Chapter 3, we provided a foundation for selecting a proper level of theory for 
futures enzymatic studies that contain 3– and 4–coordinated sulfur intermediates. In 
particular, systems that were explicitly investigated were sulfuranes from archaeal 
thioredoxin peroxidase (ApTPx)1 and methionine sulfoxide reductase (Msr A&B),2-3 
sulfinic acid, thiosulfinate and sulfinic acid phosphoryl esters from sulfuredxodin,4 
sulfonic acid from myeloperoxidase,5 sulfinamides and sulifinimines from 
myeloperoxidase6-7 and collagen IV8 respectively. In addition, we also investigated the 
relative energy difference of the common precursor sulfenic acid and its tautomer. 
Throughout our study the geometric parameters and energy values were benchmarked 
against post Hartree-Fock (HF) ab initio methods, QCISD and MP2, at very large basis 
sets, 6-311+G(2df,p) or 6-311++G(3df,3pd). From a relative energy perspective, our 
results showed that the accuracy to the benchmark calculations is strongly dependent on 
the functional used. More specifically, the HF coefficients systematically dictates the 
performance of the calculation, that is, B3LYP, B3PW91 and M06, all have between 20-
27% HF and they perform very well at a high basis set. In contrast, M06HF (100% HF) 
and M062X (~56%) overestimate the relative energy values whereas M06L (0% HF) 
underestimates them at the same basis set. This highlights the importance of 
benchmarking the system to be studied. In terms of geometry, B3LYP always over 
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predicted bond lengths in virtually all scenarios whereas M06 and M062X were 
consistently the best performers. 
In Chapter 4, we investigated a possible mechanism for the hydrolysis of DMP by 
Glycerophosphodiesterase (GpdQ). Specifically, we investigated the µ–OH directed 
mechanism as previously proposed in our group9 with homonuclear compositions. Our 
results show that mechanism could occur in a single step with the concomitant 
nucleophilic attack and protonation of the leaving group. The ordering of the calculated 
barriers are in agreement with the experimental determined kcat for the phosphodiester 
bis(p-nitrophenyl) phosphate (bpNPP).10 How the different metal combinations achieved 
remarkably different rates was explored. Our investigation suggested that reactant 
destabilization of specifically ∠ phosOα–P–phosOβ contributes mostly to the enzyme’s 
ability to speed up the reaction from the uncatalyzed hydrolysis, marked by a 39.9 kJ 
mol-1. Collectively, we hypothesized that the fine-tuning due to the metals could be two 
fold. First, the stabilization of the leaving group was predominate in the Cd(II)/Cd(II) and 
Mn(II)/Mn(II) combinations indicated by a shortening of the His82-H…phosOR coupled 
with an elongation of phosOR…phosP over the Zn(II)/Zn(II) and Co(II)/Co(II) 
combinations. Second, the increased interactions between the phosphate and the metals 
systematically increase the ∠ (phosOα–P–phosOβ) contributing up to a 11 kJ mol-1 
difference in relative energy. When extrapolating these results into a larger Ca(II)/Ca(II) 
GpdQ derivative, we determined that reactant strain was satisfactory on its own to 
explain the difference in the calculated barriers. Collectively, this work begins to provide 
a foundation for understanding a µ–OH mechanism in GpdQ that now must be compared 
the proposed terminal water mechanism. 
The final computational investigation was a preliminary study that thermodynamically 
quantifies boron’s use as a means to inhibiting β-lactamase, Chapter 5. Although this 
work is not complete, we can extrapolate information from the current results. First, we 
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modeled a β-lactam antibiotic whose mechanism is well characterized through previous 
computational work.11-12 We show computationally that potent Lewis acid in boron does 
significantly increases the rate of enzyme acylation compared to a standard β-lactam by 
58.1 kJ mol-1. This decrease can be contributed to the fact that Ser70 does not need to be 
activated prior to nucleophilic attack, as in required in of the less reactive carbonyl in a β-
lactam. However a major draw back, as previously been mentioned is the high 
reversibility of enzyme-substrate bonding. This has now been quantified with only 47.9 
kJ mol-1 to return from the “acyl enzyme” back to the reactant complex in the boron 
substitute compared to the irreversibility of β-lactam of 127.6 kJ mol-1. In light of the 
reversibility, it appears that designing a cyclic ring structure for boron may end up 
providing a good strategy to inhibit β-lactamase as shown in RPX700913 because of the 
stability of the four-coordinate boron center in the active site and subsequent hydrolysis 
could not occur in that state. Further studies are required and highly encouraged on cyclic 
boron containing ring structures to fine-tune the reversibility of this mechanism. 
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